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EFFECT OF A DIET RICH IN OLIVE OIL PHENOLICS ON AGE-RELATED 
CHANGES IN MOUSE MODEL OF AGEING AND HPLC ANALYSIS OF OLIVE 
OIL  PHENOLICS WITH ELECTROCHEMICAL DETECTOR  
SUMMARY 
Olive oil is the primary source of fat in the Mediterranean diet, which has been 
associated with reduced risk of cardiovascular mortality, cancer incidence and 
mortality and incidence of Parkinson and Alzheimer diseases. Despite the scarcity of 
clinical studies investigating the underlying mechanisms, beneficial effects of the 
Mediterranean diet have partly been attributed to the use of olive oil. It is an 
important source of monounsaturated fatty acids (mainly oleic acid). However, it has 
been suggested that the beneficial effects of olive oil consumption in the prevention 
of chronic diseases may not only be attributed to its fatty acid composition but also 
to its high content of phenolics.  
Tyrosol, hydroxytyrosol and oleuropein are the main hydrophilic phenolic 
compounds of olive oil, and their pharmacological activities reported in many in vivo 
and in vitro studies. They show beneficial effects either directly by their antioxidant 
properties or indirectly with their impact on cellular signaling pathways, expression 
of certain genes and acting as inhibitors or activators of regulatory enzymes. 
Epidemiological studies are performed in terms of their protective role on 
cardiovascular diseases, neurodegenerative diseases and cancer. 
Olive oil phenolics are well known for its antioxidant activities. But their role in 
metabolic pathways, their effect on transcription factors, gene expressions need to 
be investigated. In this study it is aimed to study the effect of diet rich in olive oil 
phenolic compounds on age-related changes in heart and liver tissues of 9-10 
weeks old female SAMP8 (Senescence Accelerated Mouse Prone 8) mice. We fed 
SAMP8 semisynthetic diets with 10% olive oil containing either high (HP) or low 
amounts of olive oil phenolics (LP) for 4.5 months. As a control SAMR1 
(senescence-accelerated mouse-resistant 1) mice were used that have a normal 
ageing process. SAMP8 is a widely used human model of ageing due to their 
shortened lifespan and pathological disorders such as elevated lipid and protein 
oxidation, inflammation, mitochondrial dysfunction, early onset of atherogenesis. 
These properties render SAMP8 mice as a suitable rodent model for experimental 
ageing research. 
Oxidative stress and inflammation play an important role in the pathogenesis of 
ageing and age-related disorders. Therefore in this study the parameters regarding 
oxidative stress and inflammation were investigated. As a biomarker of oxidative 
stress in both tissues, lipid oxidation and protein oxidation were determined by 
TBARS (Thiobarbituric acid reactive substances) assay and protein carbonyls, 
respectively. Also proteasomal activity of different subunits in the proteasomal 
system was measured. In serum of mice total cholesterol, total triglycerides, HDL 
cholesterol and paraoxonase-1 (PON-1) activity were determined. Nrf2-dependent 
gene expression may be impaired during the ageing process. In both tissues 
transcription factor Nrf2 and its target genes; glutathione-S-transferease (GST), γ-
glutamyl-cysteinyl-synthetase (γ-GCS), NADPH quionone oxidoreductase (NOQ1), 
  
xviii 
hemeoxygenase (HO-1), paraoxonase-1 (PON-1 in liver) and PON2 in heart were 
the main focus. Their amounts were determined both in mRNA level and protein 
level. Furthermore the level of antioxidant vitamins (vitamin C & E), genes that play 
a role in the metabolism of these vitamins and the parameters of redox status were 
determined.  
As a result different results in each parameter were obtained depending on the 
response of the tissue to the oxidative stress. Generally higher level of oxidative 
stress biomarkers was detected in both tissues of SAMP8 mice as compared to 
SAMR1 mice. Proteasomal activity and redox status remained unchanged in both 
tissues and mice types as well.    
Nrf2 as well GST, γ-GCS, NOQ1 and PON2 mRNA levels were significantly higher 
in heart tissue of the HP as compared to the LP group. The mRNA expression of 
HO-1 did not differ in heart with HP treatment. The mRNA expression levels of Nrf2 
and its target genes did not differ between groups in liver. Only HO-1 mRNA and 
protein level decreased in SAMP8 LP group as compared to SAMR1 LP group but 
no effect of HP treatment was observed.  
The mRNA expression level of inflammation related genes, SAP (Serum Amyloid P), 
CRP (C Reactive Protein) significantly increased and HO-1 significantly decreased 
in the liver of SAMP8 mice as compared to SAMR1 mice. Interestingly the level of 
two well known antioxidant vitamins (vitamin C & E) significantly increased in 
SAMP8 LP group. The expression of genes regarding ascorbic acid uptake and 
synthesis (sodium-dependent vitamin C transporter type 1-SVCT1, sodium-
dependent vitamin C transporter type2-SVCT2 and L-gulonolactone oxidase-Gulo) 
were also analysed. The mRNA expression level of SVCT1 expression was 
significantly increased in SAMP8 mice but no change was determined in terms of 
SVCT2 and Gulo level.  
Our data suggests that oxidative stress and inflammation may play an important role 
in the ageing of liver and heart in SAMP8 mice. Depending on the results, a diet rich 
in olive oil phenolics may prevent oxidative stress in the heart of SAMP8 mice by 
modulating Nrf2-dependent gene expression. As the two olive oil that were used in 
the feeding study compared, it has been observed that they have similar phenolic 
profile. On the other hand the HP oil contains approximately 40 fold higher 
hydroxytyrosol as compared to LP oil. Therefore the beneficial effects of the diet my 
be attributed to its hydroxytyrosol content. Vitamin C level may be a response of the 
body to oxidative stress it increased to protect the body homeostasis. This increase 
has reflected to vitamin E level, which was higher in SAMP8 LP mice.  
Another aim of that study is to develop and validate a method with the sensitive 
electrochemical detector for the quantification of olive oil phenolics in oils. 
Electrochemical detectors provide a new analytical tool for resolving and accurately 
detecting trace amounts of any electroactive compound in a wide range of samples. 
In our validated method it is possible to analyze selected phenolic compounds 
(tyrosol, hydroxytyrosol, oleuropein, pinoresinol, caffeic acid, vanillic acid, p-
coumaric acid, ferulic acid) in 17 minutes. This method was validated in terms of 
selectivity, lower limit of quantification and detection, accuracy, precision, recovery, 
short term stability, freeze thaw stability and post preparative stability. The phenolics 
were quantified in ng level. The recoveries of these phenolic compounds ranged 
between 72-96%.  
The liver and heart are the major organs responsible for a number of physiological 
processes that are crucial to sustaining life. Most of the studies dealing with SAMP8 
mice have focused on brain aging. Therefore our study could be one of the pioneer 
studies in liver and heart ageing and associated pathophysiological processes in 
SAMP8 mice. On the other hand in the literature there is only one study that uses 
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electrochemical detector in the quantification of olive oil phenolics but it is not 
validated. In this respect our validated method with good recovery of phenolics and 
lower limit of detection (ng level) will be beneficial for the future analysis of olive oil 
phenolics in shorter time.    
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ZEYTİNYAĞI FENOLİKLERİNCE ZENGİN DİYETİN YAŞLANDIRILMASI 
HIZLANDIRILMIŞ FARE MODELİNDE YAŞLANMAYA BAĞLI DEĞİŞİKLİKLER 
ÜZERİNE ETKİSİ VE ZEYTİNYAĞINDAKİ FENOLİK MADDELERİN 
ELEKTROKİMYASAL DEDEKTÖR İLE HPLC ANALİZİ   
ÖZET 
Zeytinyağı Akdeniz diyetinin temel yağ kaynağıdır. Zeytinyağı tüketimi 
kardiyovasküler hastalıklar, kanser, Parkinson ve Alzheimer gibi hastalıkların 
oluşum riskini ve bu hastalıklardan kaynaklanan ölüm riskini azaltmaktadır. Akdeniz 
diyetinin yararlı etkilerinin altında yatan mekanizmaları inceleyen klinik çalışmalar 
eksik olmasına rağmen, bu etkiler kısmen zeytinyağı tüketimine bağlanmaktadır. 
Zeytinyağı önemli bir doymamış yağ asidi (oleik asit) kaynağıdır. Ancak kronik 
hastalıkların önlenmesi ile ilişkili olarak zeytinyağı tüketiminin yararlı etkileri sadece 
yağ asidi bileşimine değil yüksek fenolik madde miktarına da bağlanmaktadır.   
Tirozol, hidroksitirozol ve oleuropein zeytinyağında bulunan temel fenolik 
bileşenlerdir ve birçok in vivo ve in vitro çalışmada farmakolojik aktiviteleri 
belirtilmiştir. Bu bileşenler yararlı etkilerini direkt olarak antioksidan özellikleri ile 
veya indirekt olarak hücresel sinyal yolizlerini, bazı genlerin anlatımını etkileyerek, 
bazı düzenleyici enzimleri aktive ya da inhibe ederek göstermektedir. Bu bileşenlerin 
kardiyovasküler hastalıklar, nörodejeneratif hastalıklar ve kanser üzerine koruyucu 
etkileri ile ilgili olarak epidemiyolojik çalışmalar gerçekleştirilmektedir.   
Zeytinyağı fenoliklerinin antioksidan aktivileri çok iyi bilinmektedir. Ancak metabolik 
yolizlerindeki görevleri, transkripsiyon faktörleri ve gen anlatımı üzerine etkilerinin 
araştırılması gerekmektedir. Bu çalışmada fenolik maddelerce zengin zeytinyağı 
içeren diyetin 9-10 haftalık dişi SAMP8 (Senescence Accelerated Mouse Prone 8) 
farelerinin kalp ve karaciğer dokularında yaşlanmaya bağlı oluşan değişiklikler 
üzerine etkisinin incelenmesi amaçlanmıştır. SAMP8 fareleri 4.5 hafta boyunca 
düşük (DF) ya da yüksek fenolik (YF) madde miktarına sahip %10 zeytinyağı içeren 
yarı sentetik diyetlerle beslenmiştir. Kontrol olarak normal yaşlanma prosesine sahip 
SAMR1 (senescence-accelerated mouse-resistant 1) fareleri kullanılmıştır. SAMP8 
fareleri düşük yaşam döngüsüne ve yüksek lipit ve protein oksidasyonu, 
iltihaplanma, mitokondri bozuklukları, erken aterogenez başlangıcı gibi patolojik 
bozukluklara sahip olduğundan dolayı insan yaşlanma modeli olarak sıklıkla 
kullanılmaktadır. Bu özellikler SAMP8 fare grubunu yaşlanma ile ilgili çalışmalarda 
kullanımını uygun kılmaktadır.   
Oksidatif stres ve iltihaplanma yaşlanma ve yaşlanmaya bağlı bozuklukların 
patogenezinde önemli rol oynamaktadır. Bu nedenle bu çalışmada oksidatif stres ve 
iltihaplanmaya bağlı parametreler incelenmiştir. Her iki dokuda da oksidatif stres 
biyomarkırı olarak lipit ve protein oksidayonu sırasıyla TBARS ve protein karbonil 
metotları ile belirlenmiştir. Ayrıca proteazomal sistemdeki farklı altbirimlerin 
proteazomal aktivitesi ölçülmüştür. Farelerin serumunda toplam kolesterol, toplam 
trigliserit, HDL kolesterol ve paraoksonaz-1 aktivitesi belirlenmiştir. Yaşlanmaya 
bağlı olarak Nrf2 (nuclear factor erythroid 2-related factor 2)’ ye bağlı gen anlatımı 
bozulabildiğinden Nrf2 ve hedef genlerinin anlatımı; glutatyon-S-transferaz (GST), γ-
glutamil-sisteinil sentetaz (γ-GCS), NADPH kuinon oksidoredüktaz (NOQ1), 
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hemoksijenaz (HO-1), paraoksonaz-1 (PON-1 karaciğerde) ve kalpte PON2, hedef 
olarak seçilmiştir. Bu genlerin miktarları mRNA ve protein seviyesinde belirlenmiştir. 
Bunun dışında antioksidan vitamin miktarları (E ve C vitamini), bu vitaminlerin 
metabolizmasında rol oynayan genler ve redoks durumu parametreleri belirlenmiştir.  
Sonuç olarak her parametrede dokuların oksidatif strese karşı yanıtına bağlı olarak 
farklı sonuçlar elde edilmiştir. Genel olarak SAMP8 farelerinin her iki dokusunda da 
oksidatif stres biyomarkırları SAMR1 farelerine göre yüksek saptanmıştır. 
Proteazomal aktivite ve redoks durumu parametreleri her iki doku ve fare tiplerinde 
degişmemiştir.   
Nrf2 ve buna bağlı GST, γ-GCS, NOQ1 ve PON2 genlerinin mRNA seviyeleri kalpte 
YF grup farelerde DF grup farelere göre önemli derecede yüksek saptanmıştır. YF 
uygulaması ile HO-1 mRNA seviyesinde bir değişim gözlenmemiştir. Karaciğerde 
Nrf2 ve hedef genlerinin anlatımında gruplar arasında fark bulunmamıştır. Sadece 
HO-1 mRNA ve protein seviyesi SAMP8 DF grubunda SAMR1 DF grubuna oranla 
düşük saptanmıştır. Ancak YF uygulamasının bir etkisi saptanmamıştır.  
Karaciğerde itihaplanma ile ilişkili olan Serum amyloid P (SAP) ve C Reaktif Protein 
(CRP) genlerinin mRNA anlatım miktarları SAMP8 DF farelerinde SAMR1 DF 
farelerine göre önemli derece artmış, HO-1 geninin mRNA miktarı ise azalmıştır. 
Ilginç olarak iki iyi tanınan antioksidan vitaminlerin miktarı (E ve C vitamini) SAMP8 
DF grubunda önemli derecede artmıştır. Sodyuma bağlı C vitamini taşıyıcısı-1 
(SVCT1), sodyuma bağlı C vitamini taşıyıcısı-2 (SVCT2), L-gulonolakton oksidaz 
gibi askorbik asidin doku içine alımı ve sentezi ile ilişkili genlerin anlatımı 
analizlenmiştir. SVCT1 anlatım miktarı SAMP8 DF grubu farelerde önemli derece 
artmış ancak SVCT2 ve L-gulonolakton oksidaz açısından bir değişiklik 
görülmemiştir.  
Elde edilen veriler SAMP8 farelerinin kalp ve karaciğer yaşlanmasında oksidatif 
stres ve iltihaplanmanın önemli rol oynayabileceğini göstermektedir. Sonuçlara bağlı 
olarak zeytinyağı fenolik maddelerince zengin diyetin SAMP8 farelerinde Nrf2 ve 
buna bağlı genlerin anlatımını düzenleyerek oksidatif stresi önleyebilecegi 
söylenebilir. Besleme çalışmalarında kullanılan iki yağ örneği karşılaştırıldığında her 
ikisinin benzer profillere sahip olduğu görülmektedir. Diğer yandan YF yağ örneği DF 
yağ örneğine göre yaklaşık 40 kat daha fazla hidroksitirozol içermektedir. Bu 
nedenle YF içeren diyetin yararlı etkileri hidroksitirozol içeriğine de bağlanabilir.   
Karaciğerde SAMP8 farelerinde görülen yüksek C vitamini miktarı oksidatif strese 
karşı vücut dengesini sağlamak için vücudun bir cevabı olarak düşünülebilir. SAMP8 
DF farelerinde görülen C vitaminindeki bu artış C vitamini tarafından indirgenen E 
vitamini miktarına da yansımıştır.  
Bu çalışmanın diğer bir amacı da hassas elektrokimyasal dedektör ile 
zeytinyağındaki fenolik maddelerin belirlenmesi için metot geliştirmek ve metodun 
validasyonunu sağlamaktır. Elektrokimyasal dedektörler pekçok üründe iz miktardaki 
elektroaktif  bileşiklerin doğru bir şekilde belirlenmesinde yeni bir analitik araç olarak 
görev yapmaktadır. Çalışmada valide edilmiş metot ile zeytinyağında bulunan 
seçilmiş fenolik maddelerin analizi (tirozol, hidroksitirozol, oleuropein, piniresinol, 
kafeik asit, vanilik asit, p-koumarik asit, ferulik asit) 17 dakika içinde yapılması 
mümkün olmuştur. Bu metot seçicilik, en düşük belirleme limit değeri, geri kazanım, 
doğruluk, duyarlık, dondurma-çözündürme dayanıklılığı, kısa süreli dayanıklılık, 
örnekleyici içindeki dayanıklılık açısından valide edilmiştir. Fenolik maddeler ng 
seviyesinde belirlenmiştir. Incelenen fenolik maddelerin geri kazanımları %72-96 
arasında saptanmıştır.  
Kalp ve karaciğer hayatı sürdürmek için gerekli pekçok fizyolojik prosesten sorumlu 
organlardır. SAMP8 fareleri ile gerçekleştirilen pekçok çalışmada beyin yaşlanması 
üzerinde durulmuştur. Bu nedenle yapılan çalışma SAMP8 farelerinde kalp ve 
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karaciğer yaşlanması ve buna bağlı patofizyolojik prosesler açısından öncü bir 
çalışma olarak değerlendirilmektedir. Diğer yandan literatürde zeytinyağının fenolik 
maddelerinin elektrokimyasal dedektör ile belirlenmesi açısından sadece bir çalışma 
mevcuttur ancak metot valide edilmemiştir. Bu açıdan valide edilmiş, fenolik 
madddelerin geri kazanımı oldukça yüksek ve en düşük belirlenme limitinin ng 
seviyesinde olduğu metot gelecekte kısa sürede fenolik madde analizi açısından 
yararlı olacaktır.  
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1. INTRODUCTION  
The ‘Mediterranean Diet is rich in olive oil, fruits, vegetables, grains and legumes. A 
high degree of adherence to the traditional Mediterranean diet has been associated 
with a reduced risk of overall and cardiovascular mortality, cancer incidence and 
mortality, and incidence of Parkinson and Alzheimer disease (Trichopoulou et al., 
2003; Sofi et al., 2008). Despite the scarcity of clinical studies investigating the 
underlying mechanisms, beneficial effects of the Mediterranean diet have partly 
been attributed to the use of olive oil (Alonso et al., 2004; Esposito et al., 2004; 
Estruch et al., 2006; Kontogianni et al., 2007). Olive oil is the primary source of fat in 
the Mediterranean diet.  
Olive oil is obtained from the fruits of Olea Europea L. tree and it contributes ~4% of 
total vegetable oil production. More than 95% of world olive oil production is 
supplied by Mediterranean countries. Due to growing interest in Mediterranean diet 
and its health benefits, the production of olive oil is now expanding to non-traditional 
producers such as United States, Canada, Australia and Japan (Visioli et al., 2002). 
Olive oil is composed of major and minor components. The major components 
represent more than 98% of the total oil weight and they include glycerols. High 
content of oleic acid is unique to olive oil. Compared to polyunsaturated fatty acids, 
oleic acid is monounsaturated, making it much less susceptible to oxidation and 
contributing to the antioxidant action, high stability and long shelf life of olive oil 
(Owen et al., 2000). The non-glycerol or unsaponifiable fraction consists of 0.4-2% 
including more than 230 chemical compounds such as sterols, aliphatic alcohols, 
triterpene alcohols, hydrocarbons, pigments, volatile compounds, and antioxidant 
compounds (Servili et al., 2004; Tripoli et al, 2005).  
Olive oil is known to have antioxidant (Liu et al., 2007; Loru et al., 2009), anti-
inflammatory (Bogani et al., 2007; Zhang et al., 2009), anti-atherogenic (Visioli and 
Galli, 2000), anti-ulcer (Serrano et al., 1997), anti-cancer (Della Regione et al., 
2000; Quiles et al., 2002; Gill et al., 2005), anti-microbial (Medina et al., 2006), 
diabetic (Soriguer et al. 2004; Al-Azzawie et al., 2006; Rigacci et al., 2009), 
neuroprotective (Schaffer et al., 2007; Young et al., 2008), skin protective (Perugini 
et al., 2008) and anti-ageing (Hao et al., 2009) effects. The overall beneficial effects 
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of virgin olive oil have been linked to both oleic acid and its antioxidant components. 
The main antioxidants of olive oil are β-carotenes and phenolic compounds 
including lipophilic and hydrophilic phenols (Boskou, 1996). While the lipophilic 
phenols, among which tocopherols can be found in other vegetable oils, some 
hydrophilic phenols of olive oil (including phenolic acids, secoiridoid compounds and 
derivatives) are not generally present in other oils and fats. Moreover, the 
hydrophilic phenols of olive oil constitute a group of secondary plant metabolites 
which show sensory and health properties (Servili et al., 2004).  
Tyrosol, hydroxytyrosol and oleuropein are the main phenolic compounds of olive 
oil, and their pharmacological activities reported in many in vivo and in vitro studies. 
They show beneficial effects either directly by their antioxidant properties or 
indirectly with their impact on cellular signaling pathways, expression of certain 
genes and acting as inhibitors or activators of regulatory enzymes. Epidemiological 
studies are performed in terms of their protective role on cardiovascular diseases, 
neurodegenerative diseases and cancer.   
The susceptibility to these diseases increases with ageing. Aging is associated with 
several changes in structure and function of different organs and tissues and it is 
characterized as a progressive decline in biological functions with time (Farooqui 
and Farooqui, 2010). One of the most accepted theories of aging is the free radical 
theory, which postulates that aging is the result of the accumulation of cellular and 
tissue damage caused by the continuous and endogenous generation of reactive 
oxygen species (ROS) (Sohal, 2002; Harman, 2003; Barja, 2004). As the amount of 
ROS increases oxidative stress occurs, that contributes to the pathogenesis and 
progression of age related disorders (Kregel and Zhang, 2007). 
Another theory for ageing is the molecular inflammation hypothesis suggesting that 
there is link between chronic, low grade inflammation and the pathogenesis of age-
related diseases, it is based on dysregulation of the immune system with age and 
altered redox status during aging. Both processes lead to activation of a wide variety 
of inflammatory mediators through overproduced reactive species during aging 
(Chung et al., 2009). 
There is a great interest in the development of anti-ageing therapies, protecting from 
the deleterious effects of ageing, and phytochemicals, dietary interventions 
containing antioxidants have been widely investigated in this respect. Olive oil, a 
food naturally containing high amounts of phenolic compounds, may be an 
alternative. To understand the effect of olive oil phenolics on ageing in vivo studies 
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are warranted. Researchers have demonstrated that several genes may modulate 
aging and influence longevity. Olive oil phenolic compounds are well known for their 
antioxidant activities. But their role in metabolic pathways, their effect on 
transcription factors, gene expressions needs to be investigated. 
In our study it is aimed to study the effect of diet rich in olive oil phenolic compounds 
on age-related changes in heart and liver tissues of SAMP8 mice, a widely used 
rodent model for experimental ageing research, which have a shorter life span and 
pathological disorders. As oxidative stress and inflammation play an important role 
in the pathogenesis of ageing and age-related disorders, the parameters regarding 
these factors were investigated. In both tissues Nrf2 and the genes that are 
controlled under that transcription factor was the main focus. Furthermore the level 
of antioxidant vitamins (vitamin C and vitamin E), biomarkers of redox status were 
measured. As a biomarker of oxidative stress, lipid oxidation was determined by 
TBARS assay, protein oxidation was determined by measuring protein carbonyl 
levels. Also proteasomal activity of different subunits in the proteasomal system was 
measured.  
Another aim of that study is to develop and validate a method with the sensitive 
electrochemical detector for the quantification of phenolics in olive oil.  
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2. LITERATURE 
2.1 Production of Olive Oil  
The most vegetable oils are extracted from seeds by solvents. On the other hand 
olive oil is produced by a cold-press mechanical process that preserves both the 
chemical nature of the oil and the natural antioxidants that are produced in response 
to environmental stress which is suggested as the uniqueness of olive oil (Visioli and 
Galli, 2000).  
The first step in olive oil production is washing of the olives in order to remove any 
foreign material that could damage machinery or contaminate the oil. Then the 
olives are crushed to produce a paste with easily extracted oil droplets. A step called 
malaxation takes place, where olive paste is mixed and prepared for separation of 
the oil from the pomace. The next step is separating the oil from the paste and fruit 
water (water of vegetation). The oil can be extracted by pressing, centrifugation, 
percolation, or through combinations of the different methods. In the last step oil is 
separated from the water. The figure 2.1 shows olive oil production with classical, 
two phase and three phase systems.  
 
          Figure 2.1: Olive oil production (Boskou, 2006). 
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2.2 Chemical Composition of Olive Oil  
Olive oil is composed of major and minor components. The major components 
include glycerols and represent more than 98% of the total oil weight. The non-
glycerol or unsaponifiable fraction consists of 0.4-2% (Servili et al., 2004; Tripoli et 
al, 2005). The chemical composition of olive oil is given in Table 2.1.  
Table 2.1: Chemical composition of olive oil. 
Saponifiable fraction (98-99%) Unsaponifiable fraction (~2%) 
Main fatty acids present in 
triacylglycerols  
Non glyceride esters (alcoholic and sterol 
compounds, waxes) 
Miristic acid (14:0) Aliphatic alcohols 
Palmitic acid (16:0) Triterpene alcohols 
Palmitoleic acid (16:1) Sterols (β-sitosterol, campesterol, estigmasterol) 
Estearic acid (18:0) Hydrocarbons (squalene, lycopene, β-carotene) 
Oleic acid (18:1) Pigments (β-carotene, chlorophylls) 
Linoleic acid (18:2) Lipophilic phenolic (Vitamin E) 
Linolenic acid (18:3) Hydrophilic phenolics (phenolic acids, phenolic 
alcohols, secoiridoids, lignans, flavones) 
 Volatile compounds 
 
Olive oil is graded in six categories: extra virgin olive oil (EVOO), virgin olive oil 
(VOO), refined olive oil, olive oil, refined residue oil, and olive residue oil. These oils 
differ in their acidity, way of production and micronutrients content. Among them 
VOO and EVOO are attributed to health effects of olive oil.  
2.2.1 Major compounds  
Triacylglycerols are constituted by most of the 12 identified fatty acids (C14-C24), 
although only 6 are major compounds. These are; oleic acid (55.23-86.64%), 
palmitic acid (6.30-20.93%), linoleic acid (2.7-20.24%), stearic acid (0.32-5.33%), 
palmitoleic (0.32-3.52%), and linolenic acid (0.11-1.52%) (Garcia-Gonzales et al.,  
2008). Virgin olive oil is unique with respect to the high oleic acid content because 
the majority of seed oils are composed primarily of polyunsaturated fatty acids, 
including the essential omega-6 fatty acid, linoleic acid. Compared to 
polyunsaturated fatty acids, oleic acid is monounsaturated, making it much less 
susceptible to oxidation and contributing to the antioxidant action, high stability and 
long shelf life of olive oil (Owen et al., 2000).  
2.2.2 Minor compounds  
Minor compounds of virgin olive oil are present in low amount and include more than 
230 chemical compounds such as sterols, aliphatic alcohols, triterpene alcohols, 
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hydrocarbons, pigments, volatile compounds, lipophilic and hydrophilic phenolic 
compounds (Servili et al, 2004). 
2.2.2.1 Lipophilic phenolics (Vitamin E) 
Vitamin E is the most abundant lipophilic phenolic. İt is a general name of four 
tocopherol (namely α-, β-, γ-, and δ-) and four tocotrienol isoforms (namely α-, β-, γ-, 
and δ-).  Virgin olive oil contains high amount of α-tocopherol in range of 50-250 
mg/kg followed by β- and γ-tocopherols (García-González et al., 2008).  
2.2.2.2 Sterols  
β-sitosterol is represent the sterol content of virgin olive oil with 90-95% that is 
followed by campesterol and stigmasterol with 3% and 1% respectively (Gutierrez et 
al., 1999). The sterol amount of virgin olive oil is approximately 1600 mg/kg (Covas 
et al., 2006). 
2.2.2.3 Hydrocarbons    
Squalene is the most important hydrocarbon of virgin olive oil which constitutes 
around 50% of the unsaponifiable matter (García-González et al., 2008). It is the 
metabolic precursor of cholesterol and other sterols and it has a role in the synthesis 
of steroid hormones. İt is found in olive oil (~0.7%) in higher amounts as compared 
to other vegetable oils (0.002-0.03%) (Reedy and Couvreur, 2009). 
2.2.2.4 Pigments  
Chlorophyll and carotenoid pigments are responsible for the color of virgin olive oil, 
ranging from yellow-green to greenish gold. The chlorophyll pigments are 
responsible for the greenish hues of virgin olive oil, with pheophytin a being a major 
compound in this regard, while the major “yellow” pigments are lutein and β-
carotene. Carotenoids are pigments whose content does not usually exceed 10 
mg/kg, with lutein being the major carotenoid followed by β-carotene and other 
xantophylls. Xantophylls esterified with fatty acids play an important role in the 
stability of carotenoids, stabilizing the oil colors and ensuring a sufficient level of 
substances with antioxidant activity (García-González et al., 2008). 
2.2.2.5 Volatile compounds  
Volatile are responsible for the olive oil flavor and aroma. They are the main 
compounds responsible for the “green” and fruity desirable aroma attributes of olive 
oil. On the contrary, the low-quality olive oil have complex profiles composed of a 
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large number of volatiles responsible for off flavors such as rancid, mustiness, fusty 
and muddy sediment (García-González et al., 2008). 
2.2.2.6 Triterpenes  
Triterpenoic alcohols (erithrodiol and uvaol) and triterpenoic acids (maslinic, 
olanolic, ursolic ane betulinic acids) are the most relevant triterpene molecules in 
virgin olive oil. They are concentrated in the pericarp of olives. Therefore it is found 
in virgin olive oil in less amount  (Covas et al., 2006).  
2.3 Health Benefits of Olive Oil  
Olive oil is characterized with its high content of monounsaturated fats and is also a 
good source of phytochemicals including phenolic compounds, squalene and 
vitamin E. It is also considered as a “natural functional food” or “liquid gold” with 
protective effects on oxidative stress and age-related disorders such as cancer, 
cardiovascular diseases, ulcer, diabetes, alzheimer and dementia. The health 
effects of olive oil is given in Figure 2.2. Many intervention studies (Tzonou et al., 
1993; Braga et al., 1998; Stoneham et al., 2000; Fung et al., 2009; Perona et al., 
2010; Martinez-Gonzalez et al., 2011) demonstrate that the lower incidence of 
cancer and cardiovascular diseases is attributed to high comsumption of olive oil in 
Mediterrenean countries. 
 
 
Figure 2.2: Health effects of olive oil. 
The overall beneficial effects of virgin olive oil have been linked to both its 
monounsaturated fatty acids (oleic acid) and its antioxidant components. It cannot 
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be explained by the effect of a single component. These compounds show their 
effect by different mechanism of actions as summarized in Table 2.2.  
In recent years many epidemiological and clinical studies have been conducted with 
phenolic compounds of virgin olive oil and more emphasis will be given to these 
compounds in the next sections including their health benefits, technological role in 
olive oil and their analysis techniques.  
Table 2.2: Mechanism of actions of olive oil components in their health effects. 
Compound  Mechanism of action  Reference  
Sterols  Protect against membrane lipid 
peroxidation, anti-inflammatory 
effect, improvement of endothelial 
dysfunction, decreases plaque 
formation, decreases LDL 
cholesterol, total cholesterol and 
triglycerides, anti-cancinogenic effect 
against lung, breast, stomach 
cancers via decrasing the growth of 
tumors, increasing the immune 
response and antioxidant enzyme 
activity 
Mendilaharsu et al., 1998; De Stefani et 
al., 2000; van Rensburg et al., 2000; 
Devaraj et al., 2006; Raitakari et al., 
2008; Hallikainen et al., 2006; Seppo et 
al., 2007 
Skualen  Protection against UV radiation and 
radioactivity  
Reedy and Couvreur, 2009 
Carotenoids Protective effect against cancer and 
cardiovascular diseases, antioxidant 
effect 
Bernstein et al., 2002; Voutilainen et al., 
2006 
Luteolin  Protective against cataract and 
macular degredation, antioxidat and 
anticarcinogenic effect, protection of 
DNA from oxidation  
Trumbo and Ellwood 2006; Santocono 
et al., 2007; Kim et al., 2007 
Chlorophylls  Antioxidant effect, protective against 
cancer 
Kamat et al., 2000; Lanfer-Marquez et 
al., 2005; Ferruzzi and Blakeslee, 2007 
α-Tocopherol Antioxidant effect, prevent oxidation 
of lipoproteins and biological 
membranes, prevent atherosclerosis, 
reduce breast cancer risk, protection 
of DNA from oxidation, 
neuroprotection  
Rimm et al., 1993; Saldeen et al., 1999; 
Kline et al., 2003 
Oleic acid  Decreases triacylglycerol and 
cholesterol, anti-inflammatory and 
antihypertensive effects, protects cell 
membrane and lipoproteins from 
oxidative stress, lowers the risk of 
colon, lung, breast, coleractal, and 
prostate cancers, improve insulin 
sensitivity, lowers plasma glucose 
and insulin levels 
Yamaki et al., 2002; Lopez et al., 2008; 
Paniagua et al., 2007; Barberger-
Gateau et al., 2007; Solfrizzi et al., 2006 
Triterpenes  Antioxidant, anti-inflammatory, 
vasodilatory, cardiotonic effects 
Somova et al., 2003; Martinez-Gonzalez 
et al., 2008 
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2.4 Hydrophilic Phenolic Compounds  
Virgin olive oil contains different classes of phenolic compounds such as phenolic 
acids, phenolic alcohols, flavonoids, hydroxy-isocromans, secoiridoids, and lignans 
as reported in Table 2.3. The most abundant phenols are the secoiridoids. These 
compounds, e.g., oleuropein and ligstroside, are derivatives of the secoiridoid 
glucosides of olive fruits. Breakdown products of two major phenolic constituents of 
the olive fruit, oleuropein and ligstroside, form the majority of the phenolic fraction. 
There are at least thirty-six structurally distinct virgin olive oil phenolics that have 
been identified (Cicerale et al., 2009). They can be grouped according to their 
similar chemical structure in the following groups: 
Phenolic acids with the basic chemical structure of C6-C1 (benzoic acids) and C6-
C3 (cinnamic acids), such as caffeic, vanillic, p-coumaric, o-coumaric, 
protocatechuic, sinapic, and p-hydroxybenzoic acid, are the first group of phenols 
observed in olive oil.  
Phenolic alcohols are the compounds with hydroxyl group attached to an aromatic 
hydrocarbon group. Hydroxytyrosol and tyrosol are the main phenolic alcohols in 
virgin olive oil. Secoiridoids are characterized by the presence of either elenoic acid 
or elenoic acid derivatives in their molecular structure (Carrasco-Pancorbo et al., 
2005). Hydroxyl-isocromans are 3,4-dihydroxy-1H-benzopyran derivatives (Bianco 
et al., 2001). Flavonoids are compounds containing two benzene rings joined by a 
linear three carbon chains, lignans are compounds which structure based on the 
condensation of aromatic aldehydes (Carrasco- Pancorbo et al., 2005). They are the 
second prevalent group in virgin olive oil.  
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Table 2.3: Phenolic compounds in virgin olive oil (Carrosco-Pancorbo et al., 2005;  
                  Servili et al., 2004). 
Phenolic acids and derivatives  
Gentisic acid  
Vanillic acid  
p-coumaric acid 
o-coumaric acid 
Gallic acid 
Caffeic acid  
Protocatechuic acid  
Ferulic acid  
Cinnamic acid  
Benzoic acid  
p-hydroxybenzoic acid  
Sinapinic acid  
4-Acetoxyethyl-1,2-dihydroxybenzene 
2-(4-hydroxyphenyl)ethyl acetate 
 
Phenolic alcohols  
(3,4-dihydroxyphenyl)ethanol (3,4 DHPEA) 
(p-hydroxyphenyl)ethanol (p-HPEA) 
(3,4-dihydroxyphenyl)ethanol glucoside 
 
Secoiridoids  
Dialdehydic form of decarboxymethyl elenoic acid linked to 3,4-
DHPEA (3,4 DHPEA-EDA) 
Dialdehydic form of decarboxymethyl elenoic acid linked to p-
HPEA (p-HPEA-EDA) 
Oleuropein aglycone (3,4 DHPEA-EA) 
Oleuropein 
p-HPEA derivative 
Dialdehydic form of oleuropein aglycone 
Dialdehydic form of ligstroside aglycone 
Ligstroside aglycone 
Oleochanthal  
 
Lignans  
(+)-1-Acetoxypinoresinol 
(+)-Pinoresinol  
(+)-1-Hydroxypinoresinol  
 
Flavonoids 
Apigenin 
Luteolin 
(+)-Taxifolin  
 
Hydroxyisochromans  
1-phenyl-6,7-dihydroxy-isochroman 
1-(3 -methoxy-4 -hydroxy)phenyl-6,7-dihydroxy-isochroman 
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2.5 Factors that Affect the Phenolic Content of Olive Oil  
The qualitative and quantitative composition of virgin olive oil hydrophilic phenols is 
strongly affected by the agronomic and technological conditions of production.  
2.5.1 Agronomic conditions  
Among agronomic parameters, the most studied aspects include cultivar, 
geographical origin, fruit ripening, climatic conditions of production and some 
agronomic techniques such as the irrigation.  
As reported, phenolic composition of fruit is affected by the cultivar (Briante et al., 
2002; Gomes-Alonso et al., 2002; Pinelli et al., 2003). Each olive cultivar has 
different phenolic content (Esti et al., 1998). For example Italian “coratina” cultivar is 
known to have higher phenolic content (Aparicio and Luna, 2002). 
Geographical origin has a great influence on phenolic composition of virgin olive oils 
(Criado et al., 2004). Depending on the olive grove, climate and altitude change, 
thus climatic conditions (rainfall, temperature, humidity) differ. 
In some aspects controversy results are obtained as there are many other factors 
that may affect the results. Several studies related to the relationships between 
irrigation during olive growing and phenolic concentration of olive oil. For instance 
Motilva et al. (1999) concluded that hydrophilic phenols in oil increase when the 
olives were grown under conditions of deficit of irrigation whereas Ismail et al. 
(1999) reported that the highest level of hydrophilic phenols in oil was obtained from 
regularly irrigated olives. Using a linear irrigation strategies Tovar et al. (2001), 
found a negative correlation between the level of water used and the concentration 
of secoiridoid derivatives of virgin olive oil, on the contrary the concentration of 
lignans was lower in the oil from the least irrigated treatment.  
Olive ripening stage is another factor for the phenolic content. As the maturity 
increases, the amount of total phenols decreases in almost all samples (Beltran et 
al., 2005; Ayton et al., 2006). During maturation, the esterase activity causes 
degradation of oleuropein, the main phenolic compound present in unripened olive 
fruit. Therefore, it is important to establish the optimal harvest time, which should 
correspond to the optimal phenol content and the best quality of oils (Skevin et al., 
2003). 
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2.5.2 Technological Conditions  
Since the occurrence of hydrophilic phenols in virgin olive oil is strictly related to the 
activities of various endogenous enzymes of olive fruit, their concentration in the oil 
is strongly affected by the extraction conditions. Crushing and malaxation are the 
most important critical points of the oil mechanical extraction process (Servili et al, 
2004). The amount of phenolics decreases as the time and the temperature of 
malaxation increases (Servili et al., 2003). Secoiridoid aglycons are originated 
during crushing from the hydrolysis of their glucosides, oleuropein, 
demethyloleuropein and ligstroside with the activity of endogenous glucosidases. It 
is reported that olives which were blanched before crushing to inactivate 
endogenous glycosidases the concentration of oleuropein and demethyloleuropein 
was not significantly modified (Servili et al., 2002). 
Extraction systems, such as pressure and centrifugation, play an important role in 
the oil phenolic composition. Oil obtained by pressure or two phase centrifugation 
systems that do not require addition of water, shows higher phenolic concentration 
in comparison to the one obtained by the traditional three phase centrifugation 
system (Kaula et al., 2006). In general, the concentration of phenols in virgin olive 
oils may range between 40 and 900 mg/kg or up to 1000 mg/kg (Montedoro et al., 
1992). 
Apart from their nutritional value phenolic compounds play an important role in 
stability, and sensory properties of olive oil.  
The phenolic constituents confer a bitter, astringent, throat-catching and pungent 
taste to the oil. Oils produced from greener olives, which contain high amount of 
phenolic compounds, have ‘‘fruity’’ and complex aroma. Conversely, ‘‘sweet’’ oils 
are almost devoid of phenols. On the other hand very high load of phenols may 
result in an excessive and unpleasant bitterness and is not synonymous with quality 
(Visioli and Galli, 2000). Oleuropein is the bitter principle of olives and is found in 
virgin olive oil as such and in its aglycone form. It undergoes hydrolysis and yields 
several simpler molecules (simple phenols) that build up the well-known olive oil 
complex taste. These modifications enhance the aroma and flavor of olive oils. Also 
strong correlation is reported between the bitter and pungent sensory notes and the 
ligstroside derivatives such as p-HPEA-EDA and 3,4-DHPEA-EDA (Gutíerrez-
Rosales et al, 2001; Tovar et al., 2001). 
Phenolic compounds also affect the stability of virgin olive oil. During storage, fatty 
acids in oils undergo oxidative degradation and odorless molecules, such as 
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hydroxyperoxides and secondary products, are produced. It is stated that virgin olive 
oil is highly stable to oxidation and has a longer shelf life as compared to other 
edible vegetable oils, due to its fatty acid composition, mainly high monounsaturated 
fatty acid content, and to the presence of minor compounds (lipophilic tocopherols 
and hydrophilic phenolic compounds) that have a major role in preventing oxidation. 
Particularly phenolic compounds contribute significantly to its prolonged shelf life 
and among them the secoiridoid derivatives show a large capacity to protect virgin 
olive oil from oxidative degradation (Gutierrez et al., 2001; Mateos et al., 2003; 
Bendini et al., 2006). Phenolic compounds can inhibit oxidation by a variety of 
mechanisms based on radical scavenging, hydrogen atom transfer, and metal-
chelating attributes (Huang et al., 2005; Prior et al., 2005). Beside it is reported that 
virgin olive oil phenolics contribute to stability of olive oil under deep-frying 
conditions (Quiles et al., 2002; Napolitano et al., 2008; Casal et al., 2010).  
2.6 Health Effects of Olive Oil Phenolics 
Tyrosol, hydroxytyrosol and oleuropein are the main phenolic compounds of virgin 
olive oil, and their pharmacological activities reported in many studies.  
Hydroxytyrosol is the principal phenolic compound found in olive oil and is known to 
possess strong antioxidant scavenging abilities. It has been reported that 
hydroxytyrosol inhibits low density lipoprotein (LDL) oxidation (Visioli, et al., 1998a), 
platelet aggregation (Petroni et al., 1995) and endothelial cell activation (Carluccio et 
al., 2003), accumulation of tromboxane and production of proinflammatory 
leukotrienes, cytokines as well as scavenge superoxide anion and hypochlorous 
acid (Visioli et al., 2002; Zhang et al., 2009). Hydroxytyrosol possesses a marked 
antioxidant activity, scavenging peroxyl radicals (Saija et al., 1998), other ROS 
(Gordon et al., 2001) and RNS (Deiana et al., 1999; de la Puerta et al., 2001), or 
breaking peroxidative chain reactions and preventing metal ion catalyzed production 
of reactive oxygen species (Gutierrez et al., 2001). Hydroxytyrosol is highly 
protective against the peroxynitrite-dependent nitration of tyrosine and DNA damage 
by peroxynitrite in vitro (Deiana et al., 1999).  
Oleuropein has been shown to possess several pharmacological properties, 
including antioxidant (Visioli et al., 2002), anti-inflammatory (Visioli et al., 1998a), 
anti-atherogenic (Carluccio et al., 2003) and anti-cancer (Owen et al., 2000) 
activities.  In addition, oleuropein has been shown to be cardioprotective against 
acute adriamycin cardiotoxicity (Andreadou et al., 2006) and to exhibit anti-ischemic 
and hypolipidemic activities (Andreadou et al., 2006). It has been suggested to 
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reduce atherosclerosis development, improve antioxidant status (González-Santiago 
et al., 2006), increase iNOS activity by scavenging superoxide anion (Visioli et al., 
1998b), increase resistance of LDL to oxidation (Coni et al., 2000). Both oleuropein 
and hydroxytyrosol have been proven to be more potent antioxidants than vitamin E 
and BHT (Visioli et al., 1998b).  
Tyrosol is the most abundant biophenol in olive oil. Tyrosol is reported to scavenge 
peroxynitrite (de la Puerta et al., 2001) and O2− (Bertelli et al., 2002). In addition to 
its antioxidative effects, it has been reported that tyrosol inhibits lipopolysaccharide 
(LPS)-induced cytokine release from human monocytes (Giovannini et al., 2002) 
and LPS-induced leukotriene B4 release in human mononuclear cells (de la Puerta 
et al., 1999). Although it has a weaker antioxidant capacity, it has been reported that 
tyrosol can restore antioxidant defense, modulate ROS and NO production, COX 
and lipoxygenase pathways (Moreno, 2003; di Benedetto et al., 2007). Tyrosol is 
able to inhibit LDL-cholesterol oxidation and to prevent the modification of the 
apoproteic moiety (Caruso et al., 1999). Tyrosol has also been effective in inhibiting 
leukocyte 5-lipooxygenase (de la Puerta et al., 1999), protecting the CaCo-2 
intestinal mucosa cells against the cytostatic effects produced by oxidized LDL 
(Giovannini et al., 1999) and inhibiting lipopolysaccharide (LPS)-induced cytokine 
release from human monocytes (Giovannini et al., 2002). Moreover, it showed a 
neuroprotective effect against the peroxynitrite-induced neuronal oxidative damage 
(Vauzour et al., 2007) and in the focal cerebral ischemia/reperfusion rat model (Bu 
et al., 2007). Some other pharmacological effects of these main phenolics are 
summarized in Table 2.4.  
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Table 2.4: Health effect of the main olive oil phenolic compounds.  
Phenolic 
compound  
Mechanism of action  Protective effect Conditions 
(Cell/mouse/human) 
Level (in vivo/ 
invitro) 
Reference  
Hydroxytyrosol  Antioxidant Scavenge hydrogen peroxide Human neutrophils In vitro  O’Dowd et al., 2004 
Antioxidant Protect from acrolein-induced 
oxidative stress and mitochondrial  
dysfunction 
Retinal pigment epithelial 
cells 
In vitro  Liu et al., 2007 
Antioxidant, antiageing  Induce Phase II enzymes, enhance 
mitochondrial biogenesis and 
improve mitochondrial function, 
strengthen the cell's antioxidant 
defenses  
3T3-L1 adipocytes 
 
In vitro  Hao et al., 2009 
Antioxidant protect cells from H2O2-induced 
damage via inhibiting production of  
MDA, hydroperoxides 
Renal proximal tubular cells In vitro Loru et al., 2009 
Antidiabetic, 
antioxidant  
inhibit hyperglycemia and oxidative 
stress induced by diabetes, increase 
antioxidant enzyme activities, 
decreases lipit peroxidation  
Diabetes rat model  In vivo  Hamden et al., 2009 
Anticancer  lower the levels of hydroxyperoxides, 
DNA damage and mRNA levels 
of classic glutathine peroxidase  
Human prostate cells  
 
In vitro  Quiles et al., 2002 
Anticancer  antiproliferative activity, induce 
apoptosis 
White blood cell from 
promyelocyticleukemia 
In vitro  Della Regione et al., 
2000 
Antioxidant, skin 
protective  
Protect against UV-B induced DNA 
damage 
HaCaT cells  In vitro  Guo et al., 2010 
Anti-inflammatory  Inhibit pro-inflammatory cytokines, 
iNOS and COX-2 expression  
Human monocytic cells In vitro Zhang et al., 2009 
Antioxidant, 
Neuroprotective  
Protect against DNA damage, 
quench radicals 
Murine-dissociated brain 
cells 
 
 
In vitro  Young et al., 2008 
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Phenolic 
compound  
Mechanism of action  Protective effect Conditions 
(Cell/mouse/human) 
Level (in vivo/ 
invitro) 
Reference  
Hydroxytyrosol  Antioxidant, 
Neuroprotective 
Attenuate Fe2+- and nitric oxide 
(NO)-induced cytotoxicity, prevents 
oxidative stress-induced loss of 
cellular ATP levels, decreases basal 
and iron-stimulated lipid peroxidation 
PC-12 cells and mouse  In vitro and ex-
vivo 
Schaffer et al., 2007 
Oleuropein 
  
Antidiabetic, 
antioxidant 
Decrease lipit peroxidation, inhibiting 
hyperglycemia , increase antioxidant 
enzyme activities 
Diabetic rabbits  In vivo  Al-Azzawie et al., 
2006 
Skin protective  Protect against UV-induced erythema 20-30 yrs females In vivo  Perugini et al., 2008 
Neuroprotective Stabilize amyloid-β structure and 
prevent the formation to a toxic β-
sheet conformation 
Model system  In vitro  Bazoti et al., 2008 
Antidiabetic  Interfere with human islet amyloid 
polypeptide (hIAPP) and protect 
against aggregate cytotoxicity in type 
II diabetes 
Rat RIN-5F insulinoma 
pancreatic β cells 
In vitro  Rigacci et al., 2009 
Tyrosol  Neuroprotective  Protect against the sensory motor 
dysfunction, neuroprotection  
Stroke rat model  In vivo  Bu et al., 2007 
Oleocanthal  
  
Anti-inflammatory  Inhibit COX-1 and COX-2 Model system  In vitro  Smith et al., 2005 
Neuroprotective  
Neuropr 
Alter aggregation of amyloid-β 
protein via changing its structure, 
immnoreactivity 
Model system  In vitro  Pitt et al, 2009 
Inhibit Tau fibrilization  Model system In vitro  Li et al., 2009 
Pinoresinol rich 
olive oil  
Anticanceronic  Decrease cell viability, induce 
apoptosis  
Colon cancer cell line  In vitro  Fini et al., 2008 
Table 2.4 (continued) : Health effect of the main olive oil phenolic compounds. 
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2.7 Analytical Determination of Phenolic Compounds In Olive Oil  
The identification and quantification of phenolic compounds are of great interest due 
to its nutritional and technological significance. The first step is the extraction of 
phenolic compounds. The most prevalent methods are solid phase extraction (SPE) 
and liquid-liquid extraction (LLE). Different cartridges are used in SPE including C8, 
C18, NH2, and diol. But more promising results are obtained with diol cartridges 
being the most suitable cartridge for phenolic analysis. In terms of recovery 
comparable results are obtained in the literature. But SPE is more advantageous 
than LLE in terms of cleanliness, simplicity, time of analysis, less amounts of 
solvents and sample required.  
For the quantitative determination of total phenols the most widely used method is 
Folin-Ciocalteu Method which is based on the reaction Folin-Ciocalteu reagent with 
the hydroxyl groups of phenolic compounds. After the colour reaction the 
absorbance is measured spectrophotometrically (Singleton et al., 1999). It is a 
simple and fast method but has low specificity as the colour reaction can occur with 
any oxidiziable phenolic hydroxyl group.  
Apart from that various methods have been developed to analyze the qualitative and 
quantitative occurrence of phenolic compounds. The simple techniques include Thin 
Layer Chromatography (TLC) (Ragazzi et al, 1973), reversed phase High 
Performance Liquid Chromatography (HPLC) coupled with Ultraviolet (UV) 
(Tsimidou et al., 1992), Diode Array Detector (DAD) (Pirisi et al., 1997; Servili et al., 
1999; Esti et al., 1998), ECD (Electrochemical Detector) (Brenes et al., 1999), Gas 
Chromatography (GC) alone (Solinas et al., 1982) or coupled with Mass 
Spectrometry (GC-MS) (Liberatore et al., 2001; Marsilio et al., 2001) and Capillary 
Electrophoresis (CE) (Bendini et al., 2003; Bonoli et al., 2004). Beside phenolic 
compounds can be determined by NMR (nuclear magnetic resonance) (Angerosa et 
al., 1995; Montedoro et al., 1993, Christophoridou et al., 2005) and IR (Infrared) 
(Montedoro et al., 1993) techniques.  
Among them LC-MS determination of phenolic compounds is the most prevalent 
technique which can determine the compounds in ng range. However it is hard to 
interpret MS results, without having any additional information about the compound. 
Another technique that is comparable with LC-MS in terms of sensitivity is 
coulometric electrode array detector (a type of Electrochemical Detector) coupled to 
HPLC. Because of a high selectivity and sensitivity, HPLC with electrochemical 
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detection has become increasingly popular for the analysis of natural antioxidants in 
food and beverages. It is frequently used in the analysis of phenolic compound in 
fruits (Aaby et al., 2005; Novak et al., 2008), vegetables (Xu et al., 2006), wort 
(Vanbeneden et al., 2006), beer (Řehov et al., 2004), beverages (Peng et al., 2005; 
Wu et al., 2007; Novak et al., 2010) and pharmaceutical analyses. Electrochemical 
detectors provide a new analytical tool for resolving and accurately detecting trace 
amounts of any electroactive compound in a wide range of samples. However in the 
literature there is only one study that uses that detector in quantification of olive oil 
phenolics.  
2.8 Principle of the Electrochemical Detector  
EC detectors apply a voltage at an electrode surface over which the HPLC eluent 
flows. Electroactive compounds eluting from the column either oxidize or reduce 
generating a current peak in real time. The amount of current generated depends on 
both the concentration of the analyte and the voltage applied, with each compound 
having a specific voltage at which it begins to oxidize (Svendsen 1993). 
There are two types of electrochemical detectors that can be coupled to LC. These 
are amperometric and coulometric detectors. Both are based in the same principle 
of oxidation/ reduction of the analyte induced by an electrode held at a fixed 
potential. In an amperometric detector, mobile phase containing analytes flows over 
a planar electrode and only partial oxidation/reduction occurs, whereas in a 
coulometric detector the carrier passes through a porous electrode, resulting in an 
increased reactive surface and therefore almost complete oxidation/ reduction. 
Thereby the sensitivity of the detector increases (Penalvo and Nurmi, 2005). 
The coulometric array detector simply consists of a series of coulometric electrode 
pairs placed in series performing a multichannel (or array) detection. The system is 
based on analytical cells containing a reference electrode that sets the 
electrochemical zero and four working electrodes that measure the redox reaction of 
interest. Each analytical cell therefore provides four channels and the systems 
available at present can bear up to four cells. It can be built up to 16 channels 
(Penalvo and Nurmi, 2005). 
2.9 Advantages of Electrochemical Detector 
-Enhanced Resolving Power: In HPLC with UV or DAD some contaminants in the 
sample co-elute with peaks of interest even after optimizing the chromatographic 
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conditions. Under, these conditions coulometric EC array detectors provide the 
separation and quantification of the co-eluting compounds have different oxidation 
potentials (Achilli et al., 1993).  
-Simplified Sample Preparation: With the increased resolving power of EC array 
detectors it is possible to separate interfering compounds from the compound of 
interest. Hence, in many instances sample clean-up procedures can be simplified 
(Svendsen, 1993).  
-The HPLC with ED is more sensitive, selective, and has a lower detection limit than 
that obtained by diode array detection. 
-Confirmation of Compound Purity: When compounds pass through the EC array 
they are normally detected on three contiguous electrodes. The first electrode will 
oxidize a small portion of the compound, the second or dominant electrode oxidizes 
a large portion of the compound and the third electrode oxidizes the remainder of 
the compound. Pure standards eluting at a given retention time will give a 
predictable response at all three electrodes and the ratio across these three 
electrodes remains constant and is independent of concentration. In real samples, 
compounds eluting at a retention time matching that of the standard can also be 
‘ratioed’ across three electrodes. If the ratio of the unknown matches the ratio of the 
standard, this can help to confirm the identity of the compound. Any difference in the 
ratio signifies that either there is some contamination of this compound with another 
unknown compound or that this compound is not the same as the standard 
compound (Svendsen, 1993).  
2.10 Mechanism of Ageing and Ageing Related Theories    
Aging is characterized as a progressive decline in biological functions with time. The 
most prominent characteristics of aging are a progressive decrease in physiological 
capacity, a reduced ability to respond adaptively to environmental stimuli, an 
increased susceptibility to diseases, and increased mortality (Farooqui and 
Farooqui, 2010). Ageing increases the susceptibility to the onset of age related 
diseases such as Alzheimer’s, Parkinson’s, diabetes, cancer, autoimmune, and 
cardiovascular diseases (Kirkwood and Austad, 2000). Aging is associated with 
several changes in structure and function of different organs and tissues. The liver is 
the major organ responsible for a number of physiological processes that are crucial 
to sustaining life. Liver ageing may disturb the liver functions.  
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In the aging of heart adverse metabolic alterations with complex changes in 
cardiovascular structure and function take place which can accelerate vascular 
degenerative diseases (Zhu et al. 2001; Ferrari et al., 2003). In addition, the 
incidence and prevalence of coronary disease, hypertension, heart failure and 
stroke increase exponentially with advanced age (Forman et al., 2010). 
Cardiovascular disease is the leading cause of death and illness in developed 
countries. It is estimated that by the year 2020 almost 40% of all deaths will be due 
to cardiovascular disease (Chung et al., 2009). 
Many ageing theories were proposed including genome instability theory which 
postulates that genomic modifications in ribosomal RNA, mitochondrial DNA play an 
important role in ageing. Telomerase theory is based on the shortening of telomeres 
due to lack of telomerase activity with ageing. Also it is stated that cell death triggers 
ageing process (Johnson et al., 1999).   
Among them the most accepted theories of aging is the free radical theory, which 
postulates that aging is the result of the accumulation of cellular and tissue damage 
caused by the continuous and endogenous generation of reactive oxygen species 
(ROS) (Sohal, 2002; Harman, 2003; Barja, 2004). Reactive species are produced 
continuously as a result of normal metabolic processes. At low levels, ROS function 
as signaling intermediates for the modulation of fundamental cell activities such as 
growth and adaptation responses. 
But if they are produced in excessive amount, ROS contribute to damage in cells 
and the imbalance between the antioxidant defense system and reactive species is 
observed. As a result oxidative stress occurs, that contribute to the pathogenesis 
and progression of age related disorders (Kregel and Zhang, 2007). 
Oxidative stress in a physiological setting can be defined as an excessive 
bioavailability of ROS, which is the net result of an imbalance between production 
and destruction of ROS (with the latter being influenced by antioxidant defenses) 
(Hagen, 2003). As a result of a rise in intracellular oxidant concentrations, various 
cell components are damaged and activation of specific signaling pathways is 
triggered. Both can influence numerous cellular processes linked to aging and the 
development of age-related diseases (Finkel and Holbrook, 2000; Valko et al., 
2007). 
The damage on cell components includes modification of molecules and other 
cellular components, and is called oxidative damage. Main targets for oxidative 
damage are proteins, lipids and nucleic acids of living organism as shown in Figure 
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2.3 and some of their oxidation products are often used as biomarkers of oxidative 
stress (Blumberg, 2004; Dalle-Donne et al, 2006). 
 
Figure 2.3: Main targets of oxidative stress.  
Another theory for ageing is the molecular inflammation hypothesis suggesting that 
there is link between chronic, low grade inflammation and the pathogenesis of age-
related diseases, it is based on dysregulation of the immune system with age and 
altered redox status during ageing. Both processes lead to activation of a wide 
variety of inflammatory mediators through overproduced reactive species during 
aging (Chung et al., 2009). 
2.11 Biomarkers of Oxidative Stress  
As a biomarker of oxidative stress there are several parameters. But in our study 
lipid peroxidation, protein oxidation, proteasomal activity, some biomarkers of 
inflammation and the mRNA expression level of some genes as a member of 
antioxidant defense system were investigated.   
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2.11.1 Lipid peroxidation  
Lipids are also important targets for oxidation by radical species. Oxidative stress 
induced peroxidation of membrane lipids leads to alterations in the biological 
properties of the membrane, such as fluidity, and can lead to inactivation of 
membrane bound receptors or enzymes, which in turn may impair normal cellular 
function and increase tissue permeability (Dalle-Donne et al., 2006). 
Lipid peroxidation has been extensively studied biomarker of oxidative stress as 
polyunsaturated fatty acid components of phospholipids in cellular membranes are 
sensitive to free radical attack. The most prevalent method is the measurement of 
lipid peroxidation by the thiobarbituric acid reactive substances (TBARS) assay, in 
which a color is produced by the reaction of aldhydic groups on products e.g., 
malondialdehyde (MDA). Besides F2-isoprostanes, and 4-hydroxy-2-nonenol (4-
HNE), which arose from free radical initiated oxidative damage of polyunsaturated 
fatty acids can be measured as a biomarker (Bokov et al., 2004). 
2.11.2 Nucleic acid oxidation  
The hydroxyl radical is known to react with DNA molecule, damaging the purine and 
pyrimidine bases and also the deoxyribose backbone. The most extensively studied 
DNA lesion is the formation of 8-OH-G. Modification of genetic material due to 
oxidative damage is known to be the first step involved in mutagenesis, 
carcinogenesis, and ageing. The level of 8-oxo-2-deoxyguanosine (oxo8dG) in DNA 
has been consistently used as a measure of oxidative damage to DNA in ageing 
(Valko et al., 2007).  
2.11.3 Protein oxidation  
As proteins are major components of biological systems and play an important role 
in many cellular functions such as signal transduction, cellular transport systems, 
age-related increase in oxidative damage to proteins could be physiologically 
important. Almost all amino acids in proteins are potential targets for oxidation by 
ROS (Bokov et al., 2004). 
Exposure of proteins to ROS may alter every level of protein structure, causing 
physical changes in protein structure. Oxidative damage to proteins lead to peptide 
backbone cleavage, cross-linking, and/or modification of the side chain of amino 
acids (Stadtman and Berlett, 1997; Davies, 1999). These oxidative modifications, 
inhibit enzymatic and binding activities, increase susceptibility to aggregation and 
proteolysis. In addition, accumulation of the modified proteins disrupts cellular 
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function either by loss of catalytic and structural integrity or by interruption of 
regulatory pathways. 
The most widely studied modification to proteins is the formation of carbonyl 
derivatives on lysine, arginine, proline, histidine, cysteine, and threonine residues. 
These biomarkers are useful indicators of redox status and have been shown to 
accumulate during ageing and age-related disease in variety of organisms 
(Stadtman and Berlett, 1997). 
2.11.4 Decreased proteasomal activity 
Proteasome is an intracellular proteolytic complex involved in a variety of cellular 
processes, including the removal of altered forms of protein, growth and 
differentiation, immune and stress response, signal transduction, aging and 
prevention of apoptosis (Zeng et al., 2005). The 20S proteasome is the proteolytic 
core of the proteasomal system. It is composed of two sets of 14 different subunits 
and has a molecular mass of 670-700 kDa. The subunits form a cylinder of four 
rings, each containing seven subunits. It has three proteolytic centers showing either 
peptidyl-glutamyl peptide hydrolyzing (β-1), trypsin-like (β-2), or chymotrypsin-like 
activity (β-5) based on the proteolysis of peptide substrates for cleavage after acidic 
basic and hydrophobic residues respectively (Breusing and Grune, 2008). It has 
been reported that proteasomal activity decreases with age (Viteri et al., 2004; 
Breusing et al., 2009).  
2.11.5 Increased inflammation  
During ageing reactive species are overproduced due to oxidative stress-induced 
redox imbalance. The main cause of age-related redox imbalance is the weakened 
anti-oxidative defense system which activates the immune systems (Brod, 2000). In 
human studies, circulating levels of pro-inflammatory cytokines such as TNF-α, IL-6, 
and IL- 1β, are well-recognized biomarkers of inflammation. Also inflammatory cell 
(neutrophils, monocytes) counts increase during aging (Bruunsgaard, 2006). 
Furthermore, aging is associated with increased levels of C-reactive protein (CRP) 
and serum amyloid P (SAP) proteins (Bruunsgaard et al., 1999). Chronic 
inflammation is a major underlying condition of many age-related diseases, such as 
atherosclerosis, cancer, diabetes, osteoporosis, dementia, vascular diseases, 
obesity and metabolic syndrome (Yu and Chung, 2006).  
 
 
25 
2.12 Protection from Detrimental Effects of Oxidative Stress 
To protect the body from detrimental effects of oxidative stress, the members of 
antioxidant defense system, including both non-enzymatic (tocopherols, vitamin C, 
glutathione, etc.) and enzymatic antioxidants (superoxide dismutases SOD, 
glutathione peroxidases, catalase, etc.) play important roles. In our study vitamin C 
and vitamin E, glutathione, uric acid, paraoxonase family members (PON-1 and 
PON-2) and Phase II enzymes were investigated.  
2.12.1 Antioxidant defense system  
2.12.1.1 Vitamin C (Ascorbic acid) 
Ascorbic acid is an essential micronutrient in primates which exhibits some of its 
biological activity due to its free radical scavenging activity. It is a water soluble 
chain breaking radical scavenger and recycles plasma membrane α-tocopherol via 
the reduction of the α-tocopheroxyl radical (May, 2000). Ascorbic acid is transported 
into mammalian cells either by the Sodium-Vitamin C Transporters, SVCT1 and 
SVCT2, which cause Na+-dependent uptake of L-ascorbate or glucose transporter 
(GLUT). Unlike humans, primates and guinea pigs, rodents such as laboratory mice 
exhibit an intact endogenous ascorbic acid synthesis since they express the rate 
limiting enzyme of vitamin C synthesis which is gulonolactone oxidase, the last 
enzyme in ascorbic acid synthesis. It has been reported that primary role of SVCT1 
is maintenance of the whole-body homeostasis, through dietary absorption and 
renal reabsorption, while SVCT2 is crucial for ascorbic acid uptake in metabolically 
active and specialized tissues, such as eye, brain, skeletal muscle and heart (Savini 
et al., 2008). Beside Kuo et al. (2004) showed that SVCTs appear to function 
independently of each other, as SVCT1 expression and the ascorbic acid 
concentration in SVCT1-predominant organs such as liver. 
2.12.1.2 Vitamin E (α-tocopherol) 
Vitamin E is a generic name for all substances exerting the biological activity of -
Tocopherol. The eight natural existing Vitamin E-compounds ( -, -, -, -
Tocopherol and , , -, -Tocotrienol) are only generated in plants and therefore 
they must be supplied to the body. -Tocopherol the most abundant form of dietary 
vitamin E, and the major lipid soluble chain-breaking antioxidant in vivo, protecting 
membranes from oxidative damage. It has been recognized as a potent inhibitor of 
lipid peroxidation in cellular membrane through the scavenging of peroxyl radicals 
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forming tocoperoxyl radicals (Burton et al., 1982). Apart from its antioxidant activity, 
it has anti-cancer, anti-atherosclerotic, and neuroprotective effects. Beside 
antioxidant gene-regulatory activities of α-tocopherol have also been described. 
Lipoproteins take part in α-tocopherol transport and its metabolism is closely linked 
to lipid and lipoprotein metabolism and common proteins are responsible for vitamin 
E metabolism. Vitamin E is absorbed in the intestine and incorporated in 
chylomicrons. After entering the circulation remnant chylomicron-associated vitamin 
E is delivered to the liver, where the α-tocopherol form is selectively incorporated 
into very low-density lipoproteins (VLDL) by the hepatic α-tocopherol transfer protein 
(TTP) and resecreted into the blood stream. Subsequently, VLDL and low-density 
lipoproteins (LDL) exchange α-tocopherol with high-density lipoproteins (HDL) 
(Kayden et al., 1993; Traber and Arai, 1999). α-tocopherol transfer from plasma to 
cells occurs by lipid transport between lipoprotein and cells. Uptake is facilitated by 
a) lipid transfer proteins and lipases (lipoprotein lipase-LPL), b) receptor-mediated 
lipoprotein endocytosis (LDL Receptor-LDLR; LDL receptor-related protein 1-LRP1), 
c) selective lipid uptake (scavenger receptor class B type I- SR-BI). Intracellular α-
tocopherol is subjected to microsomal degradation by the cytochrome P450 family 
3A (CYP3A) enzyme subfamily. Delivery of α-tocopherol to liver is facilitated by the 
activity of the α-tocopherol transport protein (α-TTP) and ATP binding cassette A1 
(ABCA1). Excessive amounts of α -tocopherol may be also excluded via the 
multidrug resistance transporter 1 (MDR1) (Huebbe et al., 2009). 
Another compound in vitamin E metabolism is Vitamin C (ascorbate) which 
regenerate the membrane bound tocoperoxyl radical to tocopherol. In turn, the 
ascorbyl radical may be regenerated to ascorbate by thiol or polyphenol antioxidants 
within the so-called antioxidant network (Packer et al., 2001).   
2.12.1.3 Glutathione (GSH) 
GSH is a tripeptide containing glutamic acid, cysteine and glycine and the 
predominant non-protein thiol. It has vital functions in the cell, including; the 
transport of amino acids, maintenance of proteins in a reduced state and protection 
of cells against reactive oxygen species, drugs or heavy metal ions, detoxifying 
electrophiles; maintaining of the cellular redox status, maintaining the essential thiol 
status of proteins by preventing oxidation of -SH groups or by reducing disulfide 
bonds induced by oxidant stress; scavenging free radicals; providing a reservoir for 
cysteine; and modulating critical cellular processes such as DNA synthesis, 
microtubular-related processes, and immune function (Lu, 1999). GSH exists 
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primarily in two redox forms, i.e., reduced GSH and glutathione disulfide (GSSG, the 
oxidized form). The GSSG/GSH ratio is considered to be the cellular redox buffer 
and it can serve as a good indicator of the cellular redox state of the cell. Redox 
state is a term that has historically been used to describe the ratio of the 
interconvertible oxidized and reduced form of a specific redox couple. It describes 
the redox environment of the cell. Redox couples in cells are, responsive to electron 
flow that changes in the reducing/oxidizing environment (Schafer and Buettner, 
2001).  
Also aminothiols such as methionine, cysteine, homocysteine take part in the 
synthesis of GSH, thus in redox state. The aminothiol metabolism that leads to GSH 
synthesis is given in Figure 2.4.  
                      
Figure 2.4 :  Aminothiol metabolism and GSH synthesis 1) Methionine adenosyl 
                     transferase 2) transmethylation reactions 3) S- adenosyl  
                     homocystein   hydrolase 4) cystathione β–synthase 5) γ-      
                     cystathionase 6) γ-glutamyl cysteine synthetase 7) GSH synthetase.  
2.12.1.4 Uric acid  
Uric acid is the final product of purine metabolism in human. In blood, it is a powerful 
antioxidant and is a scavenger of singlet oxygen, hydroxyl radical, and peroxynitrite. 
In humans, approximately one half of the antioxidant capacity of plasma comes from 
uric acid (Becker et al., 1993). Recently it has been stated that uric acid increases 
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the cysteine uptake and GSH synthesis in brain (Aoyama et al., 2011) and in liver 
(Allameh et al., 2008). 
On the other hand it has been shown that uric acid is an independent risk factor for 
cardiovascular disease and metabolic abnormalities (Bonora et al., 1996). Increased 
uric acid levels have been associated with the presence of the metabolic syndrome 
(Choi et al, 2007). Indeed, hyperuricemia often precedes the development of 
hyperinsulinemia, obesity, and diabetes (Johnson et al., 2009; Dehghan et al., 
2008). It has been reported that uric acid may also induce inflammatory responses, 
elevate serum triglyceride and cholesterol concentrations, blood glucose levels 
(Bonora et al., 1996; Lin et al., 2007).  
2.12.1.5 Paraoxonase (PON) 
Paraoxonases (PON1, PON2, and PON3) are a unique family of calcium-dependent 
hydrolases, with enzymatic activities toward a broad range of substrates (lactones, 
thiolactones, carbonates, esters, and phosphotriesters). The activity of PON1 and 
PON3 are HDL associated proteins that have been reported to contribute to the anti-
atherogenic effects of HDL (Ng et al., 2006). In contrast to PON1 and PON3, PON2 
does not associate with HDL in the circulation and it is an intracellular membrane-
associated protein. PON1 is widely expressed in liver and PON3 in liver and kidney. 
Beside PON2 is widely expressed in a number of tissues with the highest 
expression in the heart, brain, liver, lungs, and testis (Devarajan et al., 2011). 
PON1 is known as a longetivity gene (Lescai et al., 2009) and loss of PON1 activity 
with aging has been described in humans (Seres et al., 2004; Jaouad et al., 2006). 
PON-1 is an enzyme that first synthesized in the liver and subsequently released 
into the blood (Thomàs-Moyá et al., 2006). It protects LDL and HDL particles from 
oxidative stress (Aviram et al., 1998) and exerts anti-inflammatory properties 
(Dullaart et al., 2009). Low serum PON1 activity has been found in numerous 
pathological conditions, such as cardiovascular disease, type1 and 2 diabetes, 
hypercholesterolemia, metabolic syndrome and renal failure (Mackness et al., 2003; 
Lescai et al., 2009). It is suggested that PON2 may protect against oxidative stress 
(Ng et al., 2005; Reddy et al., 2008), atherosclerosis, and foam cell formation 
(Rosenblat and Aviram, 2009; Ng et al., 2006) it may act as a cellular antioxidant, 
play an antiatherogenic role (Rosenblat et al., 2006; Ng et al., 2006). It is reported 
that PON-2 deficient mice show atherosclerotic lesions with enhanced mitochondrial 
dysfunction (Devarajan et al. 2011), accumulation of triglycerides in macrophages, 
liver, aortas (Rosenblat et al., 2009; Meilin et al., 2010), increased atherosclerosis 
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(Ng et al., 2006). Decreased PON2 mRNA and protein levels were demonstrated in 
human atherosclerotic plaque areas as compared with plaque-adjacent region and 
normal artery (Fortunato et al., 2008). 
2.12.2 Phase II metabolizing enzymes 
Phase II metabolizing enzymes are the subgroup of drug metabolizing enzymes, 
which play central roles in the metabolism, elimination and/or detoxification of 
xenobiotics or exogenous compounds and drugs introduced into the human body. 
They protect the body against the potential harmful exposure to xenobiotics from the 
environment as well as certain endobiotics. In order to minimize the potential injury 
caused by these compounds, most of the tissues and organs are well equipped with 
these enzymes (Xu et al., 2005). Some of the Phase II metabolizing enzymes are 
GST, γ-GCS, NOQ-1, and HO-1. 
2.12.2.1 NADPH quionone oxidoreductase (NOQ-1) 
NOQ-1 is an enzyme that detoxifies the cycling quinones via reduction thus, it 
protects cellular membranes against oxidative damage. As a result of reduction, 
stable hydroquinones are formed that can be readily conjugated and excreted. 
NOQ-1 is known to have antioxidant properties. It takes part in the regeneration of 
antioxidant forms of ubiquinone (coenzyme Q) and Vitamin E with the reduction 
mechanism. It effectively catalyzes the reduction of a-tocopherolquinone (a product 
of vitamin E) to α-tocopherolhydroquinone, a compound which has antioxidant 
properties (Ross et al., 2000).  
2.12.2.2 Glutathione-S-transferase (GST)  
GST is one of the detoxification enzymes that catalyze the conjugation of both 
endogenous and exogenous compounds with electrophilic moiety, toxic or 
carcinogenic substrates that cause oxidative stress, with GSH. It has been 
postulated that GST activity might result in more efficient elimination of carcinogens 
and ultimately lead to cancer prevention GST catalyzes the addition of the 
glutathione moiety to a great variety of acceptor molecules. This conjugation is 
usually considered as a detoxification procedure because conjugate is degraded by 
the enzymes of the γ-glutamyl cycle (Wilkinson et al., 1997).  .  
2.12.2.3 Gamma glutamyl cysteinyl synthetase (γ-GCS) 
γ-GCS is the rate limiting enzyme in GSH synthesis and its activity is a major 
determinant of intracellular GSH homeostasis. It is composed of two subunits, 
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namely catalytic and regulatory subunits. It has been suggested that, without the 
regulatory subunit, the catalytic subunit may not have any activity under 
physiological. 
2.12.2.4 Hemeoxygenase-1 (HO-1) 
HO-1 is the rate limiting enzyme in the oxidative degradation of heme to biliverdin, 
free iron and carbon monoxide. Free heme can be quite cytotoxic, it can rapidly 
intercalate with membranes and cause severe damage. Exposure of microsomal 
membrane fractions to free heme in the presence of H2O2 leads to a dose-
dependent peroxidation of unsaturated lipids in vitro. Heme also catalyzes the 
protein peroxidation of susceptible groups in membranes (Morita et al., 2005). HO-1 
is well known for its antioxidant, anti-inflammatory, antiapoptotic and cytoprotective 
functions (Ferris et al., 1999; Petrache et al., 2000; Idriss et al., 2008). It may have 
crucial roles in the pathogenesis of cardiovascular diseases, angiogenesis, diabetes 
mellitus and cerebrovascular diseases (Idriss et al., 2008).  
All of these enzymes, GST, γ-GCS, NOQ-1, PON, HO-1 are regulated under the 
control of nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor. Nrf2 is 
an important molecular switch which orchestrates the gene expression of antioxidant 
and phase 2 enzymes, centrally involved in the ageing process (Lewis et al., 2010; 
Sykiotis et al., 2011). Nrf2 is a basic leucine zipper transcription factor that binds to 
the antioxidant response element (ARE) in the promoter region of many adaptive 
genes, such GST, γ-GCS, NQO1. Under basal conditions, Nrf2 is sequestered in the 
cytosol. Upon activation, Nrf2 is released, translocates into the nucleus where it 
heterodimerizes, binds to the ARE and subsequently increases Nrf2 target gene 
expression (Jaiswal, 2004). 
Researchers have demonstrated the role of several genes may modulate aging and 
influence longevity. The aim is to find the ways for healthy longevity rather than 
enhancing human longevity (Farooqui and Farooqui, 2010). This may be mediated 
through modulating age-related genes via phytochemicals, dietary interventions. It 
has been recently shown that hydroxytyrosol induces antioxidant/detoxificant 
enzymes and Nrf2 translocation in hepatocytes (Martin et al., 2010). Furthermore 
hydroxytyrosol induced cytoprotection against oxidative injury in vascular endothelial 
cells via Nrf2 dependent signal transduction pathway (Zrelli et al., 2011). Little is 
known about the role of olive oil phenolics on Nrf2 dependent gene expression in 
vivo.  
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Apart from Nrf2 and antioxidant enzymes, in recent years many studies have 
focused on SIRT1 gene, a class III deacetylase, that can modulate numerous 
longevity promoting cellular functions, endothelial function, lipid metabolism, cell 
cycling, gene expression, cardioprotection and aging. It decreases glucose levels, 
improves insulin sensitivity, decreases production of ROS, modulates DNA repair, 
and apoptosis (Longo and Kennedy, 2006). Furthermore activation of SIRT1 by 
polyphenols may be beneficial for regulation of oxidative stress, ageing and 
metabolism (Chung et al., 2010).  
There is a great interest in the development of anti-ageing therapies, protecting from 
the deleterious effects of ageing, and antioxidants have been widely investigated in 
this respect. Olive oil, a food naturally containing high amounts of phenolic 
compounds, may be an alternative treatment. To understand the effect of olive oil 
phenolics on ageing in vivo studies are needed in human ageing models.  
2.13 Models of Human Ageing and the Senescence-Accelerated Mouse Prone 
        (SAMP)   
In order to study human ageing yeasts, worms, flies, cells, rodents (aged rats and 
mice) are used. Among these models, senescence-accelerated mouse (SAM) is an 
animal model of human aging that is widely used in aging research.  
Rodent models may be used to understand the cellular and molecular mechanisms 
of age-dependent degeneration, and to develop dietary interventions for healthy 
ageing (Chiba et al., 2009). The senescence-accelerated mouse (SAM) is a model 
of accelerated senescence that was established through phenotypic selection from a 
common genetic pool of AKR/J strain of mice. In 1975, certain littermates of AKR/J 
mice were noticed to become senile at an early age and had a shorter life span. Five 
of these litters with early senescence were selected as the progenitors of the 
senescence-accelerated-prone mice (SAMP). Three litters with normal aging 
process were also selected as the progenitors of senescence-accelerated-resistant 
mice (SAMR). Thereafter, selective inbreeding was applied based on the degree of 
senescence, the lifespan, and the age-associated pathologic phenotypes (Butterfield 
and Poon, 2005).  
Among the two strains of SAMs, namely senescence-accelerated prone mice 
(SAMP) and senescence-accelerated resistant mice (SAMR), SAMR strain serves 
as the control strain that ages normally. Compared with the SAMR strain, the SAMP 
strain has higher oxidative stress (Sato et al., 1996, Rebrin et al., 2005; Álvarez-
García, et al., 2006), elevated biomarkers of lipid (Matsugo et al., 2000; Yasui et al., 
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2003; Rodriguez et al., 2008) and protein oxidation (Nabeshi et al., 2006; Okatani et 
al., 2002), inflammation (Tha et al., 2000), mitochondrial dysfunction (Rodriguez et 
al., 2008; Carratero et al., 2009), deteriorated antioxidative defense systems 
(Boldyrev et al., 2001), extensive liver dysfunction (Ye et al., 2004), an early onset of 
atherogenesis (Fenton et al., 2004), ultimately leading to a shorter lifespan (Takeda 
et al., 1997). These properties render SAMP8 mice as a suitable rodent model for 
experimental ageing research (Satoh et al., 2004). 
It has been reported that antioxidant compounds would have beneficial effects as 
anti-aging compounds, and several studies have been carried out to ascertain this in 
SAMP mice. Successful results were obtained by melatonin (Carratero et al. 2009, 
Garcia et al., 2010, Cuesta et al., 2010), growth hormone (Forman et al., 2010), 
Oligonol (Tomobe et al., 2007), Pycnogenol (Liu et al., 1998), green tea catechins 
(Unno et al, 2004; Kichido et al., 2007), mulberry extract (Shih et al., 2009), 
proanthocyanidins (Gong et al., 2008), lipoic acid and N-acetylcysteine (Farr et al., 
2003) as well as caloric restriction (Komatsu et al., 2008; Tajes et al., 2010) and 
exercise in combination with resveratrol (Murase et al., 2009). Most of these studies 
focused on brain aging but there is a need to research cardiological ageing that lead 
to atherosclerosis and coroner heart diseases, liver aging and associated 
pathophysiological processes in SAMP mice.  
2.14 In Vivo Studies Related to Effects of Olive Oil on Ageing  
Studies related to effects of olive oil on ageing are scarce. In the literature there are 
a few studies that are performed with aged rats. To our knowledge there is no study 
investigating the effect of olive oil on aging related disorders in SAMP8 mice but 
studies are warranted in these mice. Pitozzi et al. (2010) treated the aged rats with 
high fat feed containing phenol rich extra virgin olive oil and examined the 
parameters related to oxidative stress. At the end of the study DNA damage, lipid 
peroxidation, GSH and GSSG levels, and glutathion peroxidase, superoxide 
dismutase (SOD) and xanthan oxidase (XO) activity in the cerebral cortex, were not 
different among the groups. Also extra virgin olive oil phenols did not exert 
protective actions on motor and cognitive functions of the ageing brain, but it is 
reported that they might have an anxiety-lowering effect associated with decreased 
glutathione reductase activity and expression in the brain. In the similar study the 
endogenous levels of DNA breaks, DNA oxidized bases and TBARS in the liver did 
not differ among the treatment groups of aged rats that fed corn oil, olive oil with 
high phenolic content and olive oil with low phenolic content. However, a significant 
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increase in SOD activity and decrease in XO activity were found in the rats fed with 
high phenolic olive oil. In that group a decrease in DNA oxidative damage in blood 
cells and plasma TBARS levels, lower incidence of hypophyseal tumors and 
ulcerative dermatitis were also observed that increased with aging (Jacomelli et al., 
2010). In both studies it is reported that the high calorie diet containing large 
amounts of fat overwhelmed the possible beneficial effect of olive oil phenols. Quiles 
et al. (2004) have investigated the effects of lifelong olive oil feeding in rats, and 
found increased antioxidant capacity, reduced DNA damage and improved plasma 
lipid profile as compared to sunflower oil. Bello et al. (2006) reported a regulatory 
effect of olive oil on hepatic apoptotic pathways in aged rats with increased 
caspase-9 and caspase-3 activities as compared to rats fed with sunflower oil. Olive 
oil also decreased Bcl-2 levels, increased membrane bound Bax and decreased 
plasma membrane Mg2+-dependent neutral sphingomyelinase. The higher CoQ 
levels found in membranes from the olive oil group in aged rats was also contributed 
to a better antioxidant protection.   
2.15 Aim of the Study 
Olive oil phenolics are well known for its antioxidant activities. But their role in 
metabolic pathways, their effect on transcription factors, gene expressions need to 
be investigated. In this study it is aimed to study the effect of diet rich in olive oil 
phenolic compounds on age-related changes in heart and liver tissues of SAMP 
mice. As oxidative stress and inflammation play an important role in the 
pathogenesis of ageing and age-related disorders, the parameters regarding these 
factors were investigated. In both tissues Nrf2 and the genes that are controlled 
under that transcription factor was the main focus. Their amounts were determined 
both in mRNA level and protein level. Furthermore the level of antioxidant vitamins 
(vitamin C and vitamin E) was measured. As a biomarker of oxidative stress, lipid 
oxidation was determined by TBARS assay, protein oxidation was determined by 
measuring protein carbonyl levels. Also proteasomal activity of different subunits in 
the proteasomal system was measured.  
Another aim of that study is to develop and validate a method with the 
sensitiveelectrochemical detector for the quantification of olive oil phenolics in oils 
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3. MATERIALS AND METHOD 
3.1 Chemicals and Reagents 
HPLC grade methanol was obtained from J.T. Baker (Deventer, The Netherlands) 
and acetonitrile was obtained from Sigma Aldrich (Steinheim, Germany). Standards 
of tyrosol (CAS no. 501-94-0), vanillic acid (CAS no. 121-34-6), caffeic acid (CAS 
no. 331-39-5), p-coumaric acid (CAS no. 501-98-4), and ferulic acid (CAS no. 1135-
24-6) were purchased from Sigma Aldrich (Schnelldorf, Germany). Oleuropein (CAS 
no. 32619-42-4) and hydroxytyrosol (CAS no. 10597-60-1) were supplied by 
Extrasynthese (Genay Cedex, France) and pinoresinol by Separation Research 
(Turku, Finland). Reference standards of all analyzed compounds were HPLC grade 
with purity higher than 98% (except oleuropein, >90%). Stock solutions were 
prepared in methanol and stored at -20°C. HPLC grade 60% perchloric acid was 
obtained from Fisher Scientific (Leicestershire, UK).  
For the protein carbonyl quantification potassium chloride, mono potassium 
phosphate, sodium chloride, sodium phosphate dibasic dihydrate, disodium 
phosphate, monosodium phosphate and guanidine hydrochloride, citric acid, sulfuric 
acid, hydrogen chloride, sodium hydroxide, bovine serum albumin and Roti Quant© 
were purchased from Carl Roth GmbH (Karlsruhe, Germany). Tween 20, 2,4 
dinitrophenylhydrazine, biotin-conjugated rabbit IgG polyclonal antibody raised 
against a DNP conjugate of keyhole limpet hemocyanin (anti-DNP), 
streptavidinbiotinylated horseradish peroxidase, and o-phenylenediamine were from 
Sigma-Aldrich Chemie GmbH (Steinheim, Germany). Hydrogen peroxide was 
obtained from Merck KGaA (Darmstadt, Germany). 
3.2 Sampling of Olive Oil 
In total 57 olive oils from Italy, Spain, France, Turkey, Portugal, Australian, New 
Zealand, South Africa which were directly collected from producers or supermarkets 
were analysed in terms of their phenolic content. The oil with the lowest 
(Coopérative Oléicole du Canton d'Ollioules, France) and highest total phenolic 
content (Fratelli Ferrara s.a.s, Italy) was then chosen for the feeding study in mice.  
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3.3 Preparation of Olive Oil Extracts  
The phenolic fraction of the oil was obtained by solid-phase extraction (SPE) using 
the diol-bonded SPE cartridges (Varian, Bond Elut Diol 500 mg/3 mL) according to 
the procedure of Mateos et al. (2001). As a modification oil sample of 1.5 g was 
mixed with 1.5 mL hexane. The phenolic extract was redissolved in 1 mL methanol. 
Samples were filtered through 0.2-μm PTFE Membrane filter (Phenomenex, USA) 
into the vial. 
3.4 Spectrophotometric Determination of Total Phenolic Content  
The total phenolic content of the extracts was determined according to the Folin-
Ciocalteu spectrophotometric method (Singleton et al., 1999). Diluted Folin-
Ciocalteu reagent and 20% sodium carbonate solution were added to the phenolic 
extract. The solution was left in the dark for 45 min. The absorbance of each sample 
as well as gallic acid standards was determined at 750 nm. The results were 
expressed as mg gallic acid/kg of oil.  
3.5 HPLC Analysis of Olive Oil Phenolics  
The HPLC analyses were carried out on a Jasco system (Jasco GmbH 
Deutschland, Gross-Umstadt, Germany) consisting of a pump (PU-2085), 
autosampler (XLC-3059AS) with integrated column heater, while detection was 
carried out on 8-channel ESA Model 5600A CoulArray Detector (ESA Inc., 
Chelmsford, MA, USA). For analyte detection, increasing potentials of +250, +400, 
+500 and +750 mV were applied on channels. Separation of compounds was 
carried out on a fused core type column (Kinetex C18, 2.6μm, 100×4.6mm, 
Phenomenex, USA). Column temperature was maintained at 40°C and flow rate 
was 1.25 mL/min. Mobile phase was composed of water (solvent A), acetonitrile 
(solvent B) and methanol (solvent C) each containing 60mM LiCIO4. The pH was 
adjusted to 3.1 with perchloric acid, and the eluent was vacuum-filtered through a 
0.2 μm hydrophilic polypropylene membrane filter (Pall Corporation, Michigan, 
USA). Separation was achieved by elution gradient using an initial composition of 
96% A 3% B 1% C. The composition changed to 85% A 10% B 5% C at 4 min, 
82.5% A 11.5% B 6% C at 6 min, 65% A 24% B 11% C at 15 min and finally 
increased to 85% B 15% C at 21 min and maintained for 5 min. Initial conditions 
were reached in 5 min. The flow rate was 1.25 mL/min and injection volume was 
10μL. 
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3.6 Method Validation 
The analytical method for the determination of olive oil phenolics was validated 
according to the requirements of FDA (FDA, 2001) in terms of linearity, selectivity, 
lower limit of quantification and detection, accuracy, precision, recovery, stock 
solution stability, short term stability, freeze thaw stability and post preparative 
stability. 
3.6.1 Selectivity 
For evaluation of selectivity, phenolic compound free olive oil (Sigma Aldrich, 
Steinheim, Germany) extracted and analyzed to check for possible interference with 
the retention time of the analytes.  
3.6.2 Linearity, lower limit of detection (LLOD) and lower limit of quantification 
         (LLOQ) 
The linearity range of the detector response was performed by serial dilution of a 
stock solution of the studied compounds. Stock solutions were prepared in methanol 
and further diluted by H2O/methanol (50:50). Regression parameters were 
calculated for calibration curves. All the calibrations curves were linear over the 
range of study and were calculated by using seven points at different 
concentrations.  
The lower limit of quantification is defined as the concentration of the lowest 
standard in the analytical run which is quantified with a deviation of the actual 
concentration and a coefficient of variation of precision of less than 20%. The limit of 
detection (LOD) was the lowest detectable analyte concentration at the retention 
time where no peak of the analyte was observed.  
3.6.3 Accuracy 
The accuracy of the method was determined by five replicate analyses of quality 
control samples, which were obtained by spiking the phenolic free olive oil with 
known amounts of olive oil phenolic standards at three concentrations (low, medium, 
high). The olive oil was extracted and the calculated analyte concentrations of 
spiked oil samples were compared with the theoretical concentration values. The 
highest amount of phenolics added to the olive oil were determined according to the 
literature in order to study with realistic values. This was diluted by 4 for the middle 
concentration and by 20 for the low concentration.    
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3.6.4 Precision  
The precision of the method was determined by five replicate analyses of quality 
control samples, which were obtained by spiking the phenolic free olive oil with 
known amounts of olive oil phenolic standards at three concentrations (low, medium, 
high) on three consecutive days. The olive oil was extracted and the calculated 
analyte concentrations of spiked oil samples were compared with the theoretical 
concentration values within the same day (inter-day) and from day-to-day (intra-day) 
for three consecutive days. Values should not deviate by more then 15 % (high and 
medium concentrations) or 20 % (low concentration). The highest amount of 
phenolics added to the olive oil were determined according to the literature in order 
to study with realistic values. This was diluted by 4 for the middle concentration and 
by 20 for the low concentration.   
3.6.5 Recovery 
The recovery of phenolics calculated by analyzing five replicates for each 
concentration (low, middle, high) and comparing the detector responses with those 
of calibration standards with identical concentrations. 
3.6.6 Stock solution stability 
Inject stock solution (if necessary prepare appropriate dilution) into HPLC and store 
aliquots of the stock at -20°C and room temperature for 24 h. Compare initial 
detector response to that after 24 h storage. The stability of stock solution were 
determined for three concentration levels (low, medium and high) after storage at 
room temperature, 4°C, -20°C, -80°C for 24 h.  
3.6.7 Short term stability 
Five aliquots of spiked oil samples were prepared at 3 concentrations (low, medium 
and high). The first aliquot was analysed at 0h and remaining samples were stored 
at room temperature, 4°C, -20°C, -80°C for 24 h. To determine stability initial values 
were compared to those obtained after storage at different temperatures.  
3.6.8 Freeze thaw stability 
Three aliquots of spiked oil samples were prepared at 2 concentrations (low and 
high). Oil samples were analysed at 0h and the remaining three aliquots were frozen 
at -80°C for 24 h, thawed at room temperature and frozen again for 12-24 h at 
-80°C. The freeze-thaw-cycle were repeated two additional times. The stability was 
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determined by comparing initial values to those obtained after repeated freezing-
thawing. 
3.6.9 Post preparative stability 
Three samples of spiked olive oil with low and high concentrations were prepared in 
order to determine the stability of processed samples in the autosampler. Samples 
were injected from the same HPLC vial at 0h and compared with the injections at 6h 
intervals (6h, 12h and 18h). The cups of HPLC vial caps were replaced after each 
injection to minimize solvent loss. 
3.7 FRAP and TEAC Assays  
The FRAP assay was conducted according to Benzie and Strain (1996), using 
ascorbic acid as a reference. The TEAC assay was conducted as described by 
Miller et al. (1996) using Trolox as a reference.  
3.8 Animals and Study Design 
The animal experiment was performed according to German animal welfare laws 
and regulations and with permission of the appropriate authorities. Twenty two 
female SAMP8, aged 9-10 weeks were obtained from Harlan Winkelmann GmbH 
(Borchen, Germany). The mice were housed in groups in type II polypropylene 
cages equipped with softwood bedding, a water bottle, a mouse house and a table 
tennis ball in a climate-controlled room (temperature, 22 ± 2°C; humidity, 55 ± 5 %) 
with a 12 h light/dark cycle. One of the SAMP8 mouse died during the experiment. 
Mice were fed with pelletized Western type diet (Altromin Spezialfutter GmbH & Co. 
KG, Lage, Germany) with 0.15 % cholesterol and 20 % fat, in which 10% of fat was 
from olive oil. Mice were randomly divided into two groups. All animals had free 
access to feed and water. Food intake was controlled daily and body weights were 
controlled weekly during the 4.5 month feeding trial. At the end of the experiment the 
mice were starved before anaesthesia by CO2 and decapitated. Blood samples were 
collected in tubes and serum was separated by centrifugation (Eppendorf 5804 R, 
Rotor F34-6-38, Wesseling-Berzdorf, Germany). Tissues were excised in liquid 
nitrogen and stored at -80°C until analysed.  
 
 
40 
3.9 PON1 Arylesterase Activity in Serum  
Arylesterase activity was measured by using phenylacetate as an artificial substrate 
for PON1. Initial rates of hydrolysis were determined spectrophotometrically at 270 
nm. The assay mixture included 4 mmol/L of phenylacetate and 1 mmol/L of CaCl2 
in 20 mmol/L of Tris HCl, pH 8.0. Non-enzymatic hydrolysis of phenylacetate was 
subtracted from the total rate of hydrolysis. One unit of arylesterase activity is equal 
to 1 μmol of phenylacetate hydrolyzed per minute per milliliter (Fuhrman et al., 
2006).  
3.10 Liver and Heart Tissue Preparation 
A ratio of 1:10 homogenates of liver and 1:12 of heart were prepared with ice cold 
phosphate buffered saline (PBS) buffer (pH 7.4) at 26.000 rpm with a Miccra D-8 
homogenizer (ART Prozess- & Labortechnik GmbH & Co. KG, Mullheim, Germany). 
Homogenates were centrifuged at 4,800 g at 4°C for 10 min (Eppendorf 5804 R, 
Rotor F34-6-38, Wesseling-Berzdorf, Germany) and the supernatant was stored at -
80°C until further use.  
3.11 Lipid Peroxidation 
Lipid peroxidation was assayed fluorometrically with Tecan Infinite 200 microplate 
(Tecan Group Ltd., Crailsheim, Germany) as thiobarbituric acid reactive substances 
(TBARS) in heart homogenates after protein precipitation with TCA and extraction in 
1-butanol. Excitation and emission wavelengths were 520 nm and 560 nm, 
respectively. Calibration curve was prepared with TEP (1,1,3,3-
tetraexthoxypropane) as an external standard (Morel et al., 1983). 
3.12 Quantification of Protein Carbonyls  
Protein carbonyl content was determined in the homogenized heart tissue 
supernatant according to the ELISA method by Buss et al. (1997) with required 
modifications. The detection system used an anti-dinitrophenyl rabbit IgG-antiserum 
(Sigma Aldrich, Steinheim, Germany) as the primary antibody and a monoclonal 
antirabbit IgG antibody peroxidase conjugate (Sigma Aldrich, Steinheim, Germany) 
as the secondary antibody. Colour change was induced with o-phenylenediamine 
and H2O2. 
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3.13 Proteasomal Activity  
Twenty to fourty mg tissue was homogenized in lysis buffer (250 mM sucrose, 25 
mM HEPES, 10 mM magnesium chloride, 1 mM EDTA and 1.7 mM DTT) using a 
homogenizer (ultra-Turrax®) and afterwards centrifuged at 14,000 x g for 30 min. 
The supernatant was used for determination of protein content using the Bradford 
assay and for measurement of the proteasomal activity. For proteasomal activity, 
samples were incubated in 225 mM Tris buffer (pH 7.8), 45 mM potassium chloride, 
7.5 mM magnesium acetate, 7.5 mM magnesium chloride and 1 mM DTT. For the 
peptidyl-glutamyl like-(β1), trypsin like-(β2) and chymotrypsin like-(β5) activity the 
substrates Z-Leu-Leu-Glu-MCA (Biochem, Boston, USA), Ac-Arg-Leu-Arg-MCA 
(Biochem, Boston, USA) and N-Succinyl-Leu-Leu-Val-Tyr-MCA (Sigma Aldrich, 
Steinheim, Germany) were used, respectively. MCA liberation of the substrates was 
measured with a fluorescence reader at 360 nm excitation and 460 nm emission. 
Free MCA was utilized as a standard (Breusing and Grune, 2006). 
3.14 α-Tocopherol Analysis  
Tissue samples (50 mg) were placed in a test tube with screw-cap and 2 mL ethanol 
(EtOH) containing 1% ascorbic acid (w/v) and 700 μL H2O. Three hundred 
microlitres of saturated potassium hydroxide (KOH) solution was added, closed, 
vortexed for 10 s and incubated for 30 min at 70°C in a shaking water bath. 
Thereafter samples were immediately chilled on ice and 50 μL butylated 
hydroxytoluene (BHT)-solution (0.1% BHT in EtOH, w/v) and 2 mL n-hexane were 
added. Test tubes were mixed per hand and centrifuged 5 min at 1500 rpm. 500 μl 
of the supernatant was transferred to a clean test tube and dried at room 
temperature (Savant SpeedVac; Thermo, Langenselbold, Germany). Samples were 
reconstituted with 150 μL MeOH: H2O (98:2, v/v), and stored at 20°C until analysis. 
For quantification of the tocopherols, 40 μl of the sample were injected into an HPLC 
system (Jasco, Gross-Umstadt, Germany; pump PU2080Plus, autosampler 
AS2057Plus, detector FP2020Plus) and separated on a Waters Spherisorb ODS-2 
column (3μm, 100x4.6 mm) by isocratic elution at a flow rate of 1.2 mL/min with 
MeOH: H2O (98:2, v/v) as mobile phase. The fluorescence detector was set to an 
excitation wavelength of 290 nm and an emission wavelength of 325 nm. Peaks 
were recorded and integrated using the chromatography software Jasco 
ChromPass. The concentrations of α- and γ-tocopherol were quantified using an 
external standard curve with tocopherols (Tocopherol set, Calbiochem®, 
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Schwalbach, Germany). The same protocol was applied for the quantification of α-
tocopherol in olive oils.  
3.15 Quantification of Ascorbic Acid, GSH, GSSG, Uric Acid, Cysteine 
       Homocysteine and Methionine by HPLC with Coulometric 
       Electrochemical Detection 
Heart and liver tissue homogenates were prepared as described by Rebrin et al. 
(2005). The chromatographic separation was carried out with an autosampler 851-
AS (Jasco GmbH Deutschland, Gross-Umstadt, Germany) and a pump 510 
(Waters, Milford, MA, USA) on a Trentec Reprosil-Pur 120 C18 AQ column (150x4.6 
mm, 3 μm) from Trentec-Analysentechnik (Rutesheim, Germany) at a flow rate of 1 
mL/min. The mobile phase for isocratic elution consisted of 50 mM sodium 
phosphate monobasic and 0.25 % (v/v) acetonitrile, the pH was adjusted to 2.5 with 
85 % o-phosphoric acid, and the eluent was vacuum-filtered through a 0.2 um 
hydrophilic polypropylene membrane filter (Pall Corporation, Michigan, USA). The 
column temperature was maintained at 40°C and the analytes were quantified with 
an 8-channel ESA Model 5600A CoulArray Detector (ESA Inc., Chelmsford, MA, 
USA). For analyte detection, increasing potentials of +50, +175, +350, +600, +750 
and +825 mV were applied on channels. Serial dilutions were prepared from stock 
solutions in PBS/10 % m-phosphoric acid. The injection volume of samples and 
calibration standards was 10 μL. Each sample was analysed in duplicate. 
3.16 RNA Isolation and Real-Time Quantitative RT-PCR 
RNA was isolated from liver samples (20-30 mg) using TRIsure lysis reagent 
(Bioline, Luckenwalde, Germany). Real-time quantitative PCR was performed as a 
one-step procedure (SensiMix One-step Kit; Quantace, Berlin, Germany) with 
SybrGreen detection, using the Rotorgene cycler (Corbett Life Science, Sydney, 
Australia). Relative mRNA concentrations of genes were quantified by the use of a 
standard curve. Target gene mRNA concentration was normalized to the mRNA 
concentration of the housekeeping gene GAPDH. Primers were designed by 
standard tools (Spidey, Primer3 and NCBI Blast) and purchased from MWG 
(Ebersberg, Germany). Primer sequences for analyzed genes are summarized in 
Table 3.1.  
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Table 3.1: Primers used in real time PCR experiments. 
Primers   Sequence  Annealing temperature (°C) 
ABCA1 
 
F: CTGCCACCTCCTCAGAGAAA 55 
R: GCCATACCGAAACTCGTTCA  
CRP F: AGATCCCAGCAGCATCCATA 59 
 R: CAGTGGCTTCTTTGACTCTGC  
CYP3A F: CAAGGAGATGTTCCCTGTCA 55 
 R: CTGGTGATCACATCCATGCT  
GAPDH F: GACAGGATGCAGAAGAGATTACT 55 
 R: TGATCCACATCTGCTGGAAGGT  
γ-GCS F: AACACAGACCCAACCCAGAG 59 
R: GTCTGGCTGAGAAGCCTTTG  
Gulo  F: CCAAGATCACACCAACAAGG 57 
 R: GTCTTGGACATGCTGCTTGA  
GST F: TACTTTGATGGCAGGGGAAG 58 
R: TCATCCCGTCGATCTCTACC  
HO-1 F: GAGCCTGAATCGAGCAGAAC 59 
 R: AGCCTTCTCTGGACACCTGA  
LCAT F: TAGCAGGCTACCTGCACACA 59 
 R: GCCAGCCAGCTTCTGTAGT  
LDLrec F: AAGCTGTGACCGATGAGGAG 55 
 R: CATTGTTCAGGCCCTGCTTA  
LPL F: ATCAACTGGATGGAGGAGGA 58 
 R: CAGCTGGATCCAAACCAGTA  
LRP-1 F: AAGCTGTGACCGATGAGGAG 55 
 R: CATTGTTCAGGCCCTGCTTA  
MDR-1 F: GCCAGTATTCTGCCAAGCAT 55 
 R: CTATGAGCACACCAGCACCA  
NQO-1 F: TTCTTCTGGCCGATTCAGAGT 55 
R: TCCAGACGTTTCTTCCATCC  
Nrf2 F: GGGGACAGAATCACCATTTG 57 
R: GATGCAGGCTGACATTCTGA  
PON1 F: CAGCCTGTCCATCTGTCTCA 59 
 R: CACCCGTCTCGATTCCTTTA  
PON2 F: ATGGTGGCTCTGAGTTTGCT 57 
R: TCCTCAGCTCCAGTTTCGAT  
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Table 3.1 (continued): Primers used in real time PCR experiments. 
Primers   Sequence  Annealing temperature (°C) 
SAP 
 
F: AAGCTGCTGCTTTGGATGTT 55 
 R: CATTGTCTCTGCCCTTGACA 
SIRT1 
 
F: GTCTCCTGTGGGATTCCTGA 57 
 R: ACACAGAGACGGCTGGAACT 
SRB1 
 
F: GCAAATTTGGCCTGTTTGTT 55 
 R: GATCTTGCTGAGTCCGTTCC 
SVCT-1 
 
F: GGGAAAGCCCTCTTCTTTTC 57 
 R: TGAAGCACGTCAGGTAATGC 
SVCT-2 
 
F: TATTCCTGGGATTGCAGCAC 57 
 R: AAAGCACTGGCCTGAAACAG 
α-TTP F: GCCAAGAAGATTGCTGCTGT 58 
 R: GCAGATGAATCCGGTCCTTA 
3.17 Western Blot Analysis 
Liver tissue (20 mg) was homogenized in radio immuno precipitation assay buffer 
(50mM-Tris-HCl, 150mM-NaCl, 0·5% deoxycholate, 0·1% SDS and 1% NP-40; pH 
7·4 with protease-inhibitor cocktail, 1:100; Sigma, St Louis, MO, USA). Lysates were 
purified by centrifugation (12,000 rpm, 4°C, 20 min) after incubation on ice for 30 
min. Total protein concentrations in each lysate were quantified using a BCA Protein 
Assay kit (Pierce, Rockford, USA). Total protein of the lysates (40 μg per lane) was 
mixed with loading buffer, denatured at 95°C for 5 min and separated by 12% SDS 
gel electrophoresis followed by transferring the proteins to a PVDF membrane, 
which was then blocked for 2h in blocking buffer (3% non-fat milk in Tris-buffered 
saline, pH 7.4, with 0.05% Tween-20 (TBS/T)). Primary antibodies were diluted in 
3% non fat milk (GAPDH (Santa Cruz), 1:500; GST (Abcam), 1:3000; 1:200, NOQ-1 
(Santa Cruz), 1:500, HO-1 (Stressgen), 1:1000; Tubulin (Abcam), 1:10000) and the 
blots were incubated overnight at 4°C. The blots were washed and incubated with 
the respective IgG secondary antibodies (Santa Cruz Biotechnology, Heidelberg, 
Germany) in blocking buffer with gentle agitation for 1 h at room temperature. The 
blots were washed and exposed to Immun-Star Western Chemiluminescent kit (Bio-
Rad Laboratories, Hercules, CA, USA) and scanned with a ChemiDoc XRS system 
(BioRad, Munich, Germany). Digital images were captured and quantified by 
densitometry using the Quantity-One system (Bio-Rad). Relative concentration of 
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the proteins was quantified as the ratio between the amount of target proteins and 
the amount of the housekeeping protein α-tubulin.  
3.18 Statistical Analysis 
Results are expressed as mean values with SEM. Data were tested for normal 
distribution and analyzed by t-test. Statistical analysis was performed using PASW 
Statistics 18 (IBM, Chicago, IL, USA). Data were analysed for normality of 
distribution (Kolmogorow-Smirnov and Shapiro-Wik tests) and equality of variance 
(Levene’s test) before the t test for independent samples and in the case of non-
parametric data Mann-Whitney U test. Differences were considered significant when 
the p value was ≤ 0.05. 
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4. RESULTS AND DISSCUSSION 
4.1 Method Validation  
For the analysis of selected phenolic compounds of olive oil, the developed method 
was validated in terms of selectivity, lower limit of quantification and detection, 
accuracy, precision, recovery, short term stability, freeze thaw stability and post 
preparative stability. Although all the phenolics can be detected in 16 minutes, the 
total time of analysis for the proposed method is 30 minutes and equilibration time is 
5 minutes. The duration could not be shortened due to the fluctiations caused by the 
fast gradients, which affect the sensitivity of the detector. As compared to the other 
methods in the literature, which are longer than 40 minutes, this method gives the 
opportunity to analyze phenolic compounds in shorter time.  
4.1.1 Selectivity 
The analytical method was found to be selective for all the analytes and no 
endogenous substances were found to interfere with the compound separation. 
Representative chromatogram of the blank olive oil extract is shown in Figure 3 
(appendix A).  
4.1.2 Linearity, lower limit of detection (LLOD) and lower limit of quantification    
         (LLOQ) 
The linearity of the standard curves of the phenolic compounds was detected for ten 
points measurement. The regression coefficients of all phenolic compounds were 
over 0.99. The LLOQ and LLOD levels of the phenolics were in ng level. The linear 
range, LLOQ, LLOD of selected phenolic compounds were given in Table 4.1.  
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Table 4.1: Linear range, LLOQ, LLOD of selected phenolic compounds for  
                the method validation. 
Compound Linear range 
(μg/mL-ng/mL) 
Regression 
coefficient 
LLOD 
(ng/mL) 
LLOQ 
(ng/mL) 
Tyrosol 16.67-0.3 0.999 0.065 0.3 
Hydroxytyrosol 62.5-15.3 0.999 0.062 15.3 
Pinoresinol 33.33-2 0.999 0.5 2.0 
Oleuropein 222.22-3.4 0.999 0.11 3.4 
Caffeic acid 22.22-5.4 0.999 0.3 5.4 
Ferulic acid 27.78-3.4 0.999 1.7 3.4 
Vanillic acid 40-0.6 0.999 0.15 0.6 
p-coumaric 
acid 
22.22-1.4 0.999 0.025 1.4 
4.1.3 Accuracy, precision and recovery 
The proposed method has good accuracies and reproducibility for all the analytes at 
all three level of concentrations. The within-day and day-to-day precision have 
coefficient of variation of <15%. The extraction method was able to produce high 
recoveries (>72%) for all the analytes as well as the internal standards except 
middle concentrations of ferulic- and caffeic acid which were 65% and 58% 
respectively. Further details of the accuracy, precision and extraction recovery are 
shown in Table 4.2. The highest amount of phenolics added to the olive oil were 
determined according to the literature in order to study with realistic values. But the 
recoveries of phenolic acids (caffeic acid, ferulic acid, p-coumaric acid) were very 
bad (130-160%). Therefore the concentration of these phenolics were increased 10 
times.  
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Table 4.2: Intraday and inter-day recoveries, accuracies and precisions of  
                selected phenolic compounds of olive oil. 
 
Nominal 
concentration 
(mg/kg) 
Calculated 
concentration 
(mg/kg) 
Recovery 
[%] 
Accuracy 
[%] 
Precision 
[% CV] 
   Tyrosol  
Intraday (n=5) 1.75 1.64 93.7 6.3 2.56 
 8.75 6.50 74.3 25.7 10.15 
 35 29.89 85.4 14.6 6.93 
Interday 1.75 1.68 95.8 4.2 3.77 
 8.75 7.24 82.7 17.3 5.73 
 35 30.28 86.5 13.5 6.01 
Hydroxytyrosol 
Intraday (n=5) 2.5 1.92 76.6 23.4 3.64 
 12.5 8.05 64.4 35.6 10.34 
 50 38.65 77.3 22.7 6.69 
Interday 2.5 1.99 79.8 20.2 3.78 
 12.5 9.14 73.1 26.9 5.40 
 50 39.90 79.8 20.2 6.21 
Oleuropein 
Intraday (n=5) 0.6 0.61 100.9 -0.9 3.27 
 3 2.17 72.2 27.8 13.71 
 12 10.45 87.1 12.9 3.24 
Interday 0.6 0.56 94.1 5.9 5.75 
 3 2.19 72.9 27.1 9.45 
 12 9.79 81.6 18.4 10.88 
Pinoresinol 
Intraday (n=5) 4.75 4.12 86.8 13.2 3.57 
 23.75 17.71 74.6 25.4 12.12 
 95 84.55 89.0 11.0 7.43 
Interday 4.75 4.30 90.6 9.4 4.24 
 23.75 20.38 85.8 14.2 6.72 
 95 89.58 94.3 5.7 6.51 
Caffeic acid 
Intraday (n=5) 0.75 0.56 74.5 25.5 9 
 3.75 2.18 58.1 41.9 11.7 
 15 12.58 83.9 16.1 5.44 
Interday 0.75 0.57 76.4 23.6 7.68 
 3.75 2.76 73.5 26.5 6.16 
 15 13.23 88.2 11.8 5.79 
Ferulic acid 
Intraday (n=5) 0.75 0.67 89.9 10.1 3.85 
 3.75 2.47 65.9 34.1 14.10 
 15 13.94 92.9 7.1 4.74 
Interday 0.75 0.67 89.8 10.2 4.46 
 3.75 2.97 79.3 20.7 6.92 
 15 13.75 91.7 8.3 5.55 
Vanillic acid 
Intraday (n=5) 0.27 0.26 96.0 4.0 6.24 
 1.33 0.97 73.3 26.7 12.43 
 5.3 4.46 84.2 15.8 4.53 
Interday 0.27 0.26 95.5 4.5 5.49 
 1.33 1.05 78.9 21.1 6.55 
 5.3 4.46 84.1 15.9 5.78 
p-coumaric acid 
Intraday (n=5) 0.75 0.72 96.3 3.7 3.63 
 3.75 2.98 79.6 20.4 11.72 
 15 14.88 99.2 0.8 4.56 
Interday 0.75 0.69 91.6 8.4 4.44 
 3.75 3.19 85.2 14.8 6.10 
 15 10.80 72.0 5.0 5.37 
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4.1.4 Stability studies 
Stability studies carried out to determine whether any sample deterioration occurred 
during storage and handling. In terms of stability of stock solutions, the values of 
high and middle concentrations of phenolic compounds at three different 
temperatures were slightly different from the freshly prepared standards. However 
great differences observed for degradation of the low concentrations of 
hydroxytyrosol at -20°C (-18.31), caffeic acid at room temperature (-23.72) and -
20°C (-21.02), ferulic acid at 4°C (-12.36) (Table 4.3).  
The analytes were found to be stable after three freeze–thaw cycles as well as in 
autosampler at room temperature (Table 4.4). Regarding the short term stability and 
freeze thaw stability, the recovered amount of compounds were >85% for all 
concentrations at tested four different temperatures. In autosampler stability, greater 
degradation was observed for the low concentration of caffeic acid and oleuropein 
with 18.18% and 11.09%, respectively (Table 4.5).  
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Table 4.3: Stock solution stability of standards after 24 h storage at  
                room temperature (RT), 4°C, and -20°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                            Stock solution stability  
                                             [Degradation %] 
     RT     4°C      -20°C 
Tyrosol 
Low -6.77 3.52 5.48 
Middle -2.48 1.64 -0.45 
High -1.68 -0.89 -0.74 
Hydroxytyrosol 
Low -0.85 -6.72 -18.31 
Middle 0.62 2.00 0.32 
High -1.31 -0.20 1.52 
Oleuropein 
Low -0.57 -4.96 4.04 
Middle 0.71 2.43 0.11 
High -1.21 -0.52 -0.40 
Pinoresinol 
Low -0.64 -4.02 2.37 
Middle 2.99 1.83 0.01 
High -1.00 -0.63 -1.20 
Caffeic acid 
Low -23.72 -8.06 -21.02 
Middle 2.59 8.84 3.77 
High 1.78 1.53 2.0 
Ferulic acid 
Low -8.10 -12.36 3.60 
Middle 3.28 2.15 -0.14 
High -1.92 -1.27 -0.94 
Vanillic acid 
Low 1.40 -0.57 -1.60 
Middle -0.14 1.96 -0.14 
High -0.56 -0.04 -1.19 
p-coumaric acid 
Low 9.90 0.32 2.02 
Middle 1.45 2.07 0.26 
High -1.72 -1.19 0.21 
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Table 4.4: Freeze thaw stability and short term stability of selected phenolic 
                  compounds in olive oil at room temperature (RT), 4°C, -20°C, and -80°C. 
                            Short term stability  
                          [Degradation %] 
Freeze thaw 
stability 
[Degradation %] 
Nominal 
Concentration 
[mg/kg] 
-80°C -20°C +4°C RT 
 
Tyrosol 
1.75 -3.21 -3.70 -4.05 6.12 10.08 
35 -11.49 -10.15 -9.10 -7.46 3.95 
Hydroxytyrosol 
2.5 -2.34 -3.07 -1.02 4.39 10.33 
50 -12.46 -11.01 -9.0 -5.51 4.21 
Oleuropein 
0.6 -3.29 -5.54 -9.65 9.03 -1.56 
12 -11.71 -11.07 -9.15 -6.21 7.91 
Pinoresinol 
4.75 -6.41 -6.81 -2.71 6.61 9.03 
95 -14.45 -13.87 -12.11 -9.57 1.54 
Caffeic acid 
0.75 -5.79 -5.47 -5.14 6.82 8.05 
15 -13.73 -12.05 -10.11 -6.15 2.25 
Ferulic acid 
0.75 -4.75 -5.17 -5.97 7.61 9.28 
15 -13.23 -11.83 -7.89 -7.19 2.45 
Vanillic acid 
0.27 -5.06 -4.10 -5.63 7.44 11.33 
5.3 -14.99 -13.95 -12.40 -9.56 0.10 
p-coumaric acid 
0.75 -4.48 -4.89 -4.89 7.54 8.90 
15 -11.64 -10.34 -9.10 -6.26 -0.21 
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Table 4.5: Post preparative stability of selected phenolic compounds in olive oil. 
                                          Post preparative stability  
                                           [Degradation %] 
Nominal Concentration 
[mg/kg] 
6h 12h 18h 
Tyrosol 
1.75 0.00 0.24 0.63 
35 0.28 0.70 0.70 
Hydroxytyrosol 
2.5 -2.03 -3.93 -0.14 
50 -0.42 -0.25 1.38 
Oleuropein 
0.6 -5.64 -11.09 1.32 
12 0.05 0.21 1.43 
Pinoresinol 
4.75 -1.61 -1.85 -0.87 
95 0.19 0.00 0.95 
Caffeic acid 
0.75 -5.87 -18.18 -5.28 
15 -0.51 -1.20 -1.20 
Ferulic acid 
0.75 -1.12 -2.77 -0.12 
15 0.57 0.57 1.26 
Vanillic acid 
0.27 -0.80 -6.97 -0.45 
5.3 0.00 -0.26 -0.26 
p-coumaric acid 
0.75 -1.04 -2.25 0.69 
15 0.59 0.54 1.78 
4.2 Application of the Method for the Determination of Selected Phenolic  
       Compounds in Olive Oils 
In order to show the applicability of the developed method, the olive oil samples that 
were collected from different countries were analyzed in terms of selected phenolic 
compounds. Figure 2 in appendix shows the representative HPLC chromatogram of 
an olive oil showing the selected eight compounds.  
Table 4.6 presents the quantitative results obtained for the analysis of olive oil by 
HPLC coupled with electrochemical detector. Analyte concentrations were quantified 
by calibration curves for the phenolic compounds. 
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Sample TP TEAC FRAP α-Toc γ-Toc TY HTY OP Pino CA VA FA p-COU 
1 532±10.6 1.02±0.14 1.28±0.16 216±14 9.9±1.0 20.78± 18.87± 1.33±0.03 3.56±0.07 0.56±0.02 0.34±0.00 0.09±0.01 0.13±0.02 
2 396±7.6 0.84±0.03 0.87±0.01 263±20 5.8±0.5 8.42±0.14 4.8±0.04 0.76±0.01 3.48±0.00 0.08±0.00 0.56±0.00 0.23±0.00 1.74±0.03 
3 334±6.3 0.77±0.03 0.89±0.03 208±8.3 13.2±1.2 11.6±0.07 10.2±0.01 1.90±0.35 2.76±0.23 0.07±0.00 0.20±0.00 0.13±0.00 0.06±0.00 
4 306±4.1 0.78±0.03 0.83±0.02 181±0.3 11.2±0.7 17.2±0.49 25.3±0.49 1.27±0.13 1.41±0.01 0.19±0.09 0.21±0.05 0.25±0.01 0.43±0.01 
5 300±6.0 0.56±0.03 0.63±0.01 207±2.8 11.5±0.2 13.1±0.07 9.3±0.07 6.62±0.01 2.93±0.01 0.07±0.02 0.16±0.00 0.10±0.01 0.09±0.01 
6 286±6.5 0.61±0.02 0.72±0.02 256±1.5 13.5±0.0 24.0±0.42 22.5±0.92 1.03±0.01 2.95±0.00 0.08±0.00 0.25±0.00 0.19±0.00 0.09±0.00 
7 278±8.3 0.52±0.03 0.57±0.02 227±7.8 13.3±0.6 21.27±1.13 11.1±0.42 3.91±0.05 3.18±0.02 0.07±0.00 0.19±0.00 0.13±0.00 0.06±0.00 
8 276±4.0 0.62±0.05 0.65±0.03 58±0.7 3.8±0.1 8.0±0.28 10.7±0.18 1.36±0.00 2.79±0.03 0.07±0.00 0.79±0.02 0.2±0.01 0.02±0.00 
9 269±5.3 0.57±0.01 0.59±0.02 330±7.9 22.4±0.2 4.71±0.08 3.7±0.01 3.49±0.01 5.23±0.04 0.07±0.00 0.79±0.01 0.16±0.00 0.39±0.01 
10 268±7.5 0.49±0.05 0.54±0.02 217±10 11.0±0.6 27±1.2 16.3±0.57 10.8±0.13 5.74±0.10 0.14±0.06 0.44±0.02 0.21±0.00 0.24±0.01 
11 265±8.2 0.68±0.03 0.79±0.03 134±6.6 5.7±0.4 10.9±0.14 18.2±0.07 1,87±0.01 3.97±0.02 0.11±0.01 0.36±0.00 0.16±0.00 0.07±0.00 
12 254±6.8 0.60±0.00 0.65±0.01 172±4.9 25.6±0.7 8.1±0.14 8.2±0.07 1.71±0.01 3.38±0.02 0.07±0.00 0.20±0.00 0.14±0.00 0.05±0.00 
13 237± 6.0 0.51±0.02 0.59±0.02 252±9.5 11.9±0.3 30.75±0.99 16.6±0.35 1.39±0.01 3.6±0.04 0.09±0.00 0.34±0.01 0.18±0.00 0.19±0.01 
14 228±5.6 0.50±0.03 0.61±0.03 209±2.0 11.3±0.1 17.7±0.49 22.3±0.49 1.46±0.03 4.74±0.07 0.07±0.00 0.25±0.00 0.23±0.00 0.09±0.01 
15 224±6.9 0.53±0.01 0.61±0.04 266±10 7.3±1.7 22.1±0.3 25.7±0.1 1.81±0.02 4.6±0.01 0.11±0.02 0.16±0.00 0.14±0.00 0.12±0.00 
16 205±5.9 0.48±0.03 0.52±0.02 182±5.2 6.3±0.5 11.1±0.03 14.1±0.7 1.2±0.01 3.33±0.06 0.09±0.00 0.01±0.02 0.03±0.02 0.4±0.09 
17 205±0.7 0.50±0.00 0.40±0.01 280±4.7 21.2±0.4 4.26±0.30 4.1±0.10 0.56±0.06 6.62±0.18 0.17±0.08 0.39±0.09 0.15±0.01 0.01±0.00 
18 197±12.4 0.42±0.01 0.54±0.02 232±9.7 7.0±0.4 15.5±0.00 11.8±0.01 0.53±0.01 3.07±0.01 0.19±0.09 0.27±0.00 0.12±0.00 0.02±0.00 
19 195±9.2 0.41±0.02 0.46±0.00 259±13.6 7.8±0.3 20.1±0.21 17.2±0.14 11.3±0.04 4.35±0.04 0.07±0.00 0.14±0.00 0.15±0.00 0.03±0.00 
20 194±8.7 0.35±0.03 0.40±0.01 256±3.3 12.2±0.6 29.3±0.07 15.2±0.00 3.51±0.01 3.82±0.00 0.09±0.00 0.56±0.01 0.24±0.00 0.21±0.00 
21 191±3.9 0.44±0.01 0.48±0.00 218±0.6 6.6±0.1 12.7±0.14 8.9±0.05 1.90±0.00 3.62±0.01 0.09±0.00 0.41±0.00 0.13±0.00 0.06±0.00 
22 179±2.7 0.41±0.06 0.52±0.03 199±11.2 6.7±0.1 16.7±0.21 18.7±0.21 2.14±0.01 13.92±0.06 0.08±0.00 0.36±0.00 0.18±0.00 0.05±0.00 
23 177±3.7 0.45±0.02 0.52±0.02 120±3.4 10.5±0.5 5.38±0.19 6.6±0.07 1.47±0.01 7.51±0.09 0.07±0.00 0.17±0.00 0.12±0.00 n.d 
24 166±3.0 0.37±0.03 0.43±0.01 192±21 6.3±0.6 38.36±0.49 25.4±0.14 2.0±0.01 3.89±0.01 0.08±0.00 0.37±0.00 0.17±0.00 0.06±0.00 
25 163±6.7 0.35±0.02 0.40±0.01 256±4.7 8.3±0.5 7.38±0.99 4.6±0.29 1.75±0.04 2.86±0.14 0.08±0.00 0.34±0.16 0.11±0.00 0.01±0.00 
26 162±2.0 0.43±0.02 0.46±0.02 177±1.8 4.4±0.3 4.05±0.54 5.6±0.34 0.50±0.00 5.34±0.03 0.08±0.01 0.34±0.06 0.14±0.00 0.42±0.06 
27 159±12.6 0.40±0.01 0.43±0.03 173±11 13±0.7 9.7±0.42 11.2±0.24 1.78±0.02 1.11±0.02 0.08±0.00 0.16±0.00 0.14±0.00 0.06±0.00 
28 157±6.6 0.39±0.01 0.44±0.01 147±6.6 13.5±0.2 8.7±0.42 8.2±0.16 0.74±0.00 2.77±0.00 0.09±0.01 0.31±0.08 0.16±0.00 0.17±0.01 
29 156±9.0 0.40±0.03 0.47±0.02 133±2.3 9.3±0.2 19.3±0.01 25.3±0.14 0.65±0.00 3,3±0.00 0.09±0.00 0.21±0.00 0.14±0.00 0.09±0.00 
30 156±1.8 0.36±0.01 0.40±0.00 239±6.4 9.5±1.6 14.9±0.78 13.3±0.42 0.96±0.01 3.79±0.08 0.08±0.00 0.37±0.03 0.16±0.00 0.08±0.00 
31 153±3.5 0.33±0.03 0.35±0.01 215±6.1 7.3±0.2 13.5±0.14 9.6±0.04 0.76±0.01 2.19±0.01 0.08±0.00 0.34±0.00 0.16±0.00 0.03±0.00 
Table 4.6: FRAP, TEAC, total phenolic, α- tocopherol, γ- tocopherol and phenolic contents of collected olive oil samples. Values are expressed as mean±SD. 
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Sample TP TEAC FRAP α-Toc γ-Toc TY HTY OP Pino CA VA FA p-COU 
32 153±9.9 0.41±0.01 0.47±0.01 160±3.7 9.3±0.6 9.19±0.35 12.4±0.28 0.52±0.00 3.06±0.06 0.08±0.00 0.25±0.00 0.13±0.00 0.10±0.01 
33 147±1.8 0.32±0.04 0.39±0.02 202±6.8 7.9±0.4 12.1±0.28 6.3±0.28 0.59±0.01 3.85±0.00 0.07±0.00 0.61±0.00 0.16±0.00 0.08±0.01 
34 145±3.4 0.38±0.02 0.40±0.01 193±12 15.1±0.3 10.9±0.49 17.3±0.42 0.59±0.00 2.38±0.04 0.08±0.00 0.25±0.00 0.17±0.00 0.14±0.01 
35 145±2.7 0.37±0.02 0.42±0.01 193±4.9 14.5±1.0 30.1±0.92 19.3±0.42 0.49±0.01 2.56±0.04 0.12±0.00 0.30±0.02 0.14±0.00 0.12±0.01 
36 144±2.5 0.34±0.00 0.37±0.01 164±1.1 13.7±0.5 10.8±0.00 9.9±0.03 1.99±0.01 1.29±0.02 0.08±0.00 0.19±0.00 0.16±0.00 0.09±0.00 
37 138±2.4 0.33±0.03 0.42±0.01 240±27 15.7±1.9 10.6±0.28 12.3±0.14 1.11±0.01 10.78±0.12 0.08±0.00 0.39±0.02 0.19±0.00 0.30±0.01 
38 129±5.8 0.28±0.01 0.30±0.01 154±2.5 4.0±1.1 3.11±0.07 3.4±0.04 0.51±0.00 4.87±0.03 0.07±0.00 0.26±0.01 0.14±0.00 0.29±0.01 
39 128±1.4 0.19±0.02 0.24±0.01 289±9.3 16.3±0.4 23.5±0.21 3.7±0.01 0.37±0.00 4.15±0.02 0.09±0.00 1.45±0.01 0.24±0.00 0.13±0.01 
40 126±11.1 0.28±0.02 0.34±0.01 120±0.2 4.2±0.3 19.8±0.07 6.8±0.01 2.09±0.00 3.10±0.01 0.07±0.00 0.20±0.00 0.14±0.00 0.10±0.00 
41 124±0.9 0.22±0.02 0.29±0.01 264±17 6.3±0.4 7.3±0.14 3.9±0.04 0.34±0.02 3.5±0.03 0.08±0.00 0.48±0.01 0.16±0.00 0.07±0.00 
42 122±3.3 0.33±0.01 0.43±0.01 209±4.4 6.5±0.2 3.96±0.11 4.6±0.10 0.41±0.00 4.57±0.01 0.09±0.00 0.60±0.00 0.18±0.00 0.16±0.00 
43 121±3.4 0.29±0.01 0.34±0.00 202±0.3 14.7±0.7 28.9±1.06 3.0±0.04 0.42±0.00 2.27±0.04 0.10±0.00 0.23±0.01 0.13±0.00 0.11±0.00 
44 118±2.8 0.15±0.02 0.16±0.00 97±2.6 4.8±0.1 20.4±1.56 1.1±0.01 0.68±0.06 1.43±0.04 0.17±0.08 0.20±0.02 0.15±0.01 0.16±0.01 
45 116±1.9 0.25±0.00 0.30±0.00 240±9.3 8.0±0.4 7.32±0.14 3.5±0.04 1.57±0.02 3.11±0.01 0.09±0.01 0.20±0.00 0.12±0.00 n.d 
46 114±5.7 0.25±0.01 0.32±0.01 281±8.5 12.0±0.3 8.64±0.35 3.6±0.07 0.38±0.01 2.94±0.04 0.08±0.00 0.20±0.00 0.15±0.00 0.50±0.01 
47 112±2.3 0.26±0.02 0.32±0.01 171±1.5 6.3±0.2 8.2±0.07 6.6±0.09 0.45±0.00 6.02±0.00 0.08±0.00 0.51±0.00 0.20±0.00 0.26±0.00 
48 109±2.5 0.14±0.02 0.22±0.00 38±0.2 4.0±0.1 3.61±0.05 0.2±0.04 0.49±0.00 4.32±0.04 0.07±0.00 0.26±0.01 0.13±0.00 n.d 
49 107±1.3 0.33±0.03 0.24±0.01 167±6.7 9.3±0.3 16.2±0.49 6.7±0.14 2.64±0.55 2.17±0.02 0.64±0.09 0.30±0.17 0.19±0.08 0.42±0.02 
50 104±3.8 0.27±0.02 0.30±0.01 152±5.1 3.7±0.2 7.1±0.00 7.7±0.01 2.7±0.01 3.5±0.01 0.08±0.00 0.16±0.00 0.14±0.00 0.14±0.01 
51 101±1.1 0.23±0.00 0.27±0.01 181±7.0 8.0±0.3 4.60±0.04 3.5±0.01 2.0±0.00 1.87±0.00 0.08±0.01 0.16±0.00 0.12±0.00 0.01±0.00 
52 100±0.4 0.27±0.01 0.36±0.00 164±1.1 13.7±0.5 4.1±0.16 4.1±0.04 0.38±0.01 4.49±0.06 0.08±0.00 0.62±0.01 0.19±0.00 0.16±0.01 
53 91±1.3 0.16±0.01 0.21±0.00 201±4.5 5.9±0.1 6.7±0.57 2.8±0.12 0.59±0.04 2.17±0.08 0.07±0.00 0.17±0.00 0.13±0.00 0.04±0.00 
54 88±0.9 0.18±0.02 0.26±0.00 138±2.1 5.7±1.2 7.9±0.28 2.7±0.05 0.42±0.00 2.13±00.04 0.07±0.00 0.20±0.02 0.17±0.00 0.63±0.03 
55 83±2.6 0.18±0.01 0.22±0.00 209±1.0 14.8±0.2 11.7±0.42 3.0±0.04 0.39±0.01 1.50±0.02 0.09±0.00 0.46±0.00 0.16±0.01 0.30±0.02 
56 69±1.1 0.18±0.01 0.22±0.01 188±1.0 7.3±0.1 4.51±0.07 3.8±0.03 0.49±0.00 4.26±0.02 0.07±0.00 0.15±0.00 0.12±0.00 0.08±0.00 
57 45±3.2 0.11±0.01 0.18±0.00 197±15 13.2±1.3 7.03±0.05 0.54±0.01 1.19±0.03 1.86±0.02 0.91±0.03 0.15±0.01 0.08±0.02 0.19±0.00 
Table 4.6 (continued): FRAP, TEAC, total phenolic, α- tocopherol, γ- tocopherol and phenolic contents of collected olive oil samples. Values are expressed  
                                      as mean ± SD. 
Abbreviations: TP; total phenolic, α-Toc; alpha tocopherol, γ-Toc; gamma tocopherol, TY; tyrosol, HTY; hydroxytyrosol, OP; oleuropein, Pino; pinoresinol, 
FA; ferulic acid, CA; caffeic acid, VA; vanillic acid, p-COU; p-coumaric acid,n.d; not detected. Values are expressed as mg/kg 
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4.3 Animal Study 
In this study, we have focused on investigating the effects of olive oil naturally rich in 
phenolic compounds on several oxidative stress and inflammation parameters in 
SAMP8 mice. It is important to take into account that in the present study, we used a 
Western type diet with 20% fat, in which 10% fat replaced by olive oil and 0.15% 
cholesterol to trigger the oxidative stress in mice. Western type diet is a human diet 
of many countries associated with increased risk of atherosclerosis and CHD (Fung 
et al., 2009; Perona et al., 2010). The content of antioxidant vitamins was kept low 
but adequate and synthetic antioxidants and flavonoids were completely excluded 
from the diet in order to minimize their impact on the outcome of the experiment. 
The two oils that are used in the study were identical for major and minor 
constituents (Table 4.7). 
 Table 4.7: Concentrations of phenols and TEAC and FRAP values of the high- 
                  polyphenol (HP) and low-polyphenol (LP) olive oils.  
 
High-polyphenol 
olive oil 
Low-polyphenol 
olive oil 
Phenolic compounds [mg/kg oil]   
       Tyrosol 20.78 7.03 
       Hydroxytyrosol 18.87 0.54 
       Pinoresinol 3.56 1.85 
       Oleuropein 1.33 1.19 
       Caffeic acid  0.56 0.91 
       Vanillic acid  0.34 0.16 
       p-coumaric acid  0.13 0.20 
       Ferulic acid  0.09 0.08 
       α-Tocopherol  217 197 
Total phenolics [mg GA equivalent/kg 
oil] 
532 44 
FRAP [mmol AA equivalent/kg oil] 1.27 0.17 
TEAC [mmol trolox equivalent/kg oil] 1.01 0.11 
4.3.1 Body weight and feed intake  
At the end of the 4.5-month feeding trial, no differences were observed in the final 
body weight and daily feed intake of mice fed the HP and LP diets, as shown in 
Table 4.8. 
 
 
 
 
 
 
57 
Table 4.8: Body weight and food intake of SAMR1 and SAMP8 mice fed either with 
                  high or low phenolic diet. 
 SAMR1 LP SAMP8 LP SAMP8 HP 
Body Weight (g) 31.15±0.45 29.12±1.31 27.19±1.43 
Food intake (g/day) 2.42±0.01 3.13±0.07 3.26±0.48 
Values are expressed as mean±SEM (n=10) 
4.3.2 Effect of age and HP diet on serum parameters 
In serum samples of mice PON1 activity was measured as a marker of the age-
associated oxidative status. Arylesterase activity was measured, which is more 
closely related to the levels of PON1 protein (Costa et al., 2005) thus, more 
indicative of the status of the PON1 enzyme. Significant decrease was found in 
aged SAMP8 LP mice as compared to SAMR1 LP mice (p<0.001). Feeding the 
mice with a HP diet increased the PON-1 activity in serum of mice (p<0.05, Figure 
4.1). The change in PON-1 activity may stem from either HDL levels or PON1 
transcription in liver. But no significant difference was found either in serum HDL 
level between groups (Table 4.9) or PON-1 mRNA expression in liver (Figure 4.7). 
According to our results the difference in arylesterase activity cannot be attributed to 
changes in these parameters due to the fact that no significant difference of HDL 
levels in serum and PON-1 mRNA expression levels were determined in liver. This 
decline in PON-1 activity may be related to increased oxidative stress with aging 
(Seres et al., 2004) and the increase in PON-1 activity may be related to effect of 
HP diet.  
In serum, total triglyceride levels did not differ among groups on the other hand total 
cholesterol levels were significantly decreased in SAMP8 LP mice (p<0.001). The 
effect of age and diet on serum biochemical parameters (total cholesterol, total 
triglyceride and HDL) is given in Table 4.9.  
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Figure 4.1: Mean (±SEM) PON1 activity in serum of SAMR1 and SAMP8 mice fed a 
                   Western type diet with 0.15% cholesterol and 20% fat, in which 10% of fat  
                   was from olive oil containing either LP or HP (n=9). 
Table 4.9 : Serum parameters of SAMR1 and SAMP8 mice. 
 SAMR1 LP SAMP8 LP SAMP8 HP 
HDL [mg/dl] 92±8.1 63.3±15 59.5±11 
Total cholesterol [mg/dl] 160±3.1 116±6.9*** 105±2.9 
Total triglyceride [mg/dl] 120±13 142±13 110±9.3 
Values are expressed as mean± SEM (n=6-10) ***p<0.001 SAMR1-LP vs SAMP8-LP. 
4.3.3 Effect of age and hp diet on oxidative stress biomarkers  
In order to determine the effect of ageing on lipid peroxidation and protein oxidation, 
TBARS, protein carbonyl levels and proteasomal activity were determined in liver 
and heart tissues of mice. In liver significantly higher TBARS (p<0.01) and protein 
carbonyl levels (p<0.05) were obtained in SAMP8 LP mice as compared to SAMR1 
LP mice (Table 4.10). No effect of HP diet was observed on TBARS levels but level 
of protein carbonyls decreased with HP treatment (p<0.05). In order to detect if the 
change in protein carbonyl level is related to proteasomal activity, we measured the 
activity of subunits of proteasomal system. Proteasomal activity of the β-1, β-2 and 
β-5 subunits in liver tissue remained unchanged (Table 4.10). 
In heart TBARS levels were interestingly lower in SAMP8 LP mice as compared to 
SAMR1 mice (p<0.05). As observed in liver, treatment with phenolic rich olive oil 
significantly decreased TBARS levels of SAMP8 mice as compared to SAMP8 LP 
mice (p<0.001, Table). Protein carbonyl levels were higher in SAMP8 LP than that 
of SAMR1 LP (p<0.05, Table 4.11) and a significant decrease was observed in with 
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HP diet as compared to LP diet (p<0.01, Table 4.11). In terms of proteasomal 
activities, no significant difference was observed in terms of β-2 and β-5 subunits 
among groups, whereas activity of β-1 subunit was decreased in SAMP8 LP mice 
as compared to SAMR1 LP mice (p<0.05). No effect of HP treatment was observed 
in SAMP8 mice (p>0.05, Table 4.11).   
Table 4.10: Concentrations of TBARS and protein carbonyls as well as proteasomal 
                  activities in liver homogenates from SAMR1 and SAMP8 mice fed a 
                  Western type diet with 0.15% cholesterol and 20% fat, in which 10%  
                  of fat was from olive oil containing either LP or HP for 4.5 months. 
 SAMR1 LP SAMP8 LP SAMP8 HP 
TBARS [nmol/g tissue] 442±35 700±78** 663±48 
Protein carbonyls [nmol/g protein] 775±36 874±36* 730±46## 
Proteasomal activity [μmol/mg*min]    
  β-1 subunit  32.8±2.1 31.1±2.9 31.2±6.7 
  β-2 subunit  6.2±0.2 6.1±0.1 5.9±0.2 
  β-5 subunit 56.7±5.7 40.9±3.1 49.7±4.2 
Values are expressed as mean ± SEM (n=10) 
*
p<0.05 SAMR1-LP vs SAMP8-LP, 
**
p<0.01 
SAMR1-LP vs SAMP8-LP 
##
p<0.01 SAMP8-LP vs SAMP8-HP. 
Table 4.11: Concentrations of TBARS and protein carbonyls as well as proteasomal 
                  activities in heart homogenates from SAMR1 and SAMP8 mice fed 
                  diets with 10% olive oil for 4.5 months. 
 SAMR1 LP SAMP8 LP SAMP8 HP 
TBARS [nmol/g tissue] 563±46 428±27* 274±22### 
Protein carbonyls [nmol/g protein] 763±33 959±70* 665±37## 
Proteasomal activity [μmol/mg*min]    
  β-1 subunit  29.6±1.0 26.1±1.0* 31.7±3.4 
  β-2 subunit  6.9±0.4 8.2±0.5 6.8±0.5 
  β-5 subunit 72.2±6.9 93.0±9.2 79.3±11 
Values are expressed as mean ± SEM (n=10) 
*
p<0.05 SAMR1-LP vs SAMP8-LP, 
##
p<0.01 
SAMP8-LP vs SAMP8-HP,
###
 p<0.001 SAMP8-LP vs SAMP8-HP. 
 
Depending on the age and analyzed organs different profiles can be observed in 
literature regarding TBARS and protein carbonyl levels of SAMP8 mice. Nabeshi et 
al. (2006) determined higher protein carbonyl levels in liver at 3 and 6 mouth of age 
however results did not differ at 9 month of age, and in brain higher levels were 
detected at 3 month of age but no difference was found at 6 and 9 month of age. 
Higher TBARS level was observed in brain of SAMP8 mice as compared to ddY 
mice at 11 month of age but no difference was found at 3 month of age. Matsugo et 
al. (2000) found increased TBARS level in heart at 3 and 6 month of age but the 
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results did not differ in SAMP8 mice of 9 month of age. In the study performed by 
Okatani et al. (2002) no difference was observed in TBARS level of SAMP8 brain at 
the age of 6 and 12 month but protein carbonyl levels significantly increased. In 
another study no age related difference was found in terms of TBARS and protein 
carbonyls in brain of SAMP8 mice (Sato et al., 1996). Similarly no effect of treatment 
and age on protein carbonyl levels was found in the heart of SAMP8 mice by 
Schiborr et al. (2010). 
As a general consensus the decline in proteasomal activity is one of the parameters 
for oxidative stress, and aging but controversy results are obtained depending on 
the age, tissue, and different region of tissues. In addition three catalytic sites of 
proteasome can be differentially affected in aged tissues. It has been reported that 
proteasomal activity decreased significantly with age in lung and liver samples but 
not in heart, kidney and skeletal muscle (Breusing et al., 2009). El mohsen et al. 
(2004) reported that proteasomal enzyme activity was not affected by age in any of 
the brain regions (cortex, cerebellum and hippocampus) of rats. Also no difference 
between subunits were found in young and aged Wistar rats (Gavilan et al., 2009), 
Fisher 344 rats (Kavazis et al., 2007). Age-dependent inhibition of β-5 subunit 
activity in the retinal pigment epithelium of Fischer 344 rats were reported 
(Kapphahn et al., 2007). Lower expression of β-2 and β-5 catalytic subunits in 
peripheral blood T lymphocytes was detected during aging (Ponnapannan et al., 
2007). Activities of β-1 and β-2 subunits were diminished with age, while β-5 activity 
did not exhibit significant alterations in different age groups of Fisher 344 rat hearts 
(Bulteau et al., 2002). Age-dependent protein modifications and declining 
proteasome activity in the human lens detected in all catalytic subunits of age group 
>60 but just β-1 subunit activity declined in age group of 25-55 years (Viteri et al., 
2004). By contrast there was a 3-fold increase (Ferrington et al., 2005) and 4- fold 
increase in β-1 and β-5 subunits in aged muscle of Fischer 344 rats (Husom et al., 
2004).  
4.3.4 Effect of age and HP diet on redox status  
As indicators of the redox status, we measured concentrations of the GSH and 
oxidized GSH (GSSG), aminothiols (methionine, homocysteine and cysteine) and 
the antioxidant uric acid in liver and heart. Homocysteine level could not be 
measured in both tissues as the concentration was above the standard range. No 
difference was found in GSH, GSSG, GSH/GSSG, methionine and uric acid 
between groups in liver of mice (Table 4.12). Cysteine level was significantly higher 
in SAMP8 LP as compared to SAMR1 group (p<0.05).  
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Table 4.12: The concentration of GSH, GSSG, GSH/GSSG, cysteine, methionine 
                  and uric acid in liver of SAMR1 and SAMP8 mice at 7 month of age. 
 SAMR1 LP SAMP8 LP SAMP8 HP 
GSH [nmol/mg protein] 28.9±5.2 31.9±3.0 38.6±5.9 
GSSG [nmol/mg protein] 0.63±0.11 0.94±0.14 1.05±0.13 
GSH/GSSG [nmol/mg protein] 38.1±3.7 31.3±4.0 37.2±3.2 
Cysteine [nmol/mg protein] 0.50±0.07 0.68±0.05* 0.75±0.08 
Methionine [nmol/mg protein] 1.68±0.14 1.61±0.15 1.74±0.36 
Uric Acid [nmol/mg protein] 0.67±0.13 0.88±0.10 0.68±0.09 
Values are expressed as mean± SEM (n=10).  
*
p<0.05 SAMR1-LP vs SAMP8-LP. 
 
In heart GSSG and thus GSH/GSSG could not be measured as the concentration 
was below the calibration range. No difference was found in GSH and methionine 
level between groups in heart of mice (Table 4.13). Cysteine and uric acid levels 
were significantly higher in SAMP8 LP as compared to SAMR1 group (p<0.05). 
Feeding the mice with HP diet decreased both parameters significantly (p<0.05) as 
compared to SAMP8 LP mice.     
Table 4.13: The concentration of GSH, GSSG, GSH/GSSG, cysteine, methionine 
                  and uric acid in heart of SAMR1 and SAMP8 mice at 7 month of age. 
 SAMR1 LP SAMP8 LP SAMP8 HP 
GSH [nmol/mg protein] 3.97±0.57 4.80±0.57 3.66±0.74 
Cysteine [nmol/mg protein] 0.14±0.03 0.22±0.04* 0.14±0.03# 
Methionine [nmol/mg protein] 0.27±0.04 0.39±0.08 0.20±0.06 
Uric Acid [nmol/mg protein] 0.25±0.04 0.55±0.13* 0.23±0.04# 
Values are expressed as mean± SEM (n=10).  No significant difference was found. 
  
Cysteine is a sulfydryl-containing amino acid which shows cytotoxicity in vitro and 
promotes detachment of human arterial endothelial cells in culture (Dudman et al., 
1991). It also exhibits autooxidation properties in the presence of metal ions 
resulting in the generation of free radicals and hydrogen peroxide (Hogg, 1999). It is 
indicated that cysteine could be atherogenic as it supports superoxide- mediated 
modification of LDL, thus facilitating foam cell formation (Verhoef et al., 1996; El-
Khairy et al., 2001). Furthermore increased cysteine levels associate with 
cardiovascular diseases (Mills et al., 2000; Jacob et al., 1999). In addition to its 
antioxidant activity, uric acid is another cardiovascular risk factor which can promote 
LDL oxidation in vitro and liberate peroxide and superoxide free radical. 
Hyperuricemia is considered to be a risk factor in many clinical conditions including 
hypertension, cardiovascular diseases (Nakanishi et al., 2003; Strazzullo and Puig, 
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2007). In our study elevated levels of cysteine and uric acid was detected in heart of 
SAMP8 LP group as compared to SAMR1 LP group indicating a susceptibility of 
SAMP8 for cardiovascular diseases (p<0.05). Phenolic rich diet improved the both 
parameters significantly (p<0.05, Table 4.13). Schiborr et al. (2010) did not find any 
significant difference either between the hearts of SAMP8 and SAMR1 mice or 
treatment groups regarding cysteine and uric acid levels. Rebrin and Sohal (2004) 
reported significantly lower levels of cysteine in blood of SAMP mice as compared to 
C57BL/6 mice at 13 month of age.  
4.3.5 Effect of age and HP diet on antioxidant vitamins in liver  
Age related alterations of two important endogenous vitamins, ascorbic acid and α-
tocopherol, which are related to inflammation and oxidative stress were also 
measured. Ascorbic acid is an essential micronutrient in primates which exhibits 
some of its biological activity due to its free radical scavenging activity. It is a water 
soluble chain breaking radical scavenger and recycles plasma membrane α-
tocopherol via the reduction of the α-tocopheroxyl radical (May, 2000). It exhibited a 
2 fold increase in SAMP8 LP mice than those in SAMR1 LP. No change was 
observed in vitamin C level in heart of SAMP8 and SAMR1 mice (Figure 4.2 A-B).  
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Figure 4.2 A-B: Mean (±SEM) vitamin C concentration (nmol/mg protein) in liver A) in heart 
              B) of SAMR1 and SAMP8 mice fed a Western type diet with 0.15% 
                        cholesterol and 20% fat, in which 10% of fat was from olive oil containing 
                          either low or high amount of phenolics (n=10). 
The mechanisms for increased ascorbic acid levels may include increased synthesis 
and/or transport of that vitamin (Siqueira et al., 2011). Ascorbic acid is transported 
into mammalian cells by two types of proteins: the sodium-ascorbate co-
transporters, SVCT1 and SVCT2, which cause Na+-dependent uptake of L-
ascorbate. Gluconolactone oxidase (Gulo) is the last enzyme in ascorbic acid 
synthesis. Therefore the mRNA expression level of these genes was also 
measured. The level of SVCT1 mRNA expression was significantly increased in 
SAMP8 LP mice as compared to SAMR1 but no change was determined in terms of 
SVCT2 and Gulo (Table). Treatment with HP diet increased Gulo mRNA expression 
as compared to SAMP8 LP mice but SVCT1 and SVCT2 remained unchanged 
(Table 4.14).   
 
 
 
 
 
 
 
 
A) B) 
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Table 4.14: Relative mRNA expression (normalized for GAPDH) of SVCT1, SVCT2 and 
                    Gulonolactone oxidase in liver of SAMR1 and SAMP8 mice fed for 4.5 months 
                    a Western type diet with 0.15% cholesterol and 20% fat, in which 10% of fat 
                    was from olive oil containing either low or high amount of phenolics. Mice were 
                    killed at 7 months of age.  
 SAMR1 LP SAMP8 LP SAMP8 HP 
SVCT1 0.62±0.05 0.84±0.09* 0.80±0.08 
SVCT2 0.70±0.14 0.55±0.10 0.70±0.09 
Gulonolactone oxidase  0.54±0.07 0.59±0.08 0.88±0.07# 
Values are expressed as mean ± SEM (n=10). *p<0.05 SAMR1-LP vs SAMP8-LP, 
#
p<0.05 
SAMP8-LP vs SAMP8-HP. 
 
As ascorbic acid recycles α-tocopherol, we determined the age- and ascorbic acid 
related change of that lipid soluble vitamin. In the same manner α-tocopherol 
exhibited a 2 fold increase in SAMP8 LP mice than those in SAMR1 LP mice (Figure 
4.3). Also mice fed HP diet exhibited increased α-tocopherol levels as compared to 
SAMP8 LP mice (Figure 4.3).  
 
 
Figure 4.3: Mean (±SEM) vitamin E concentration (mmol/mg protein) in liver of SAMR1 and 
              SAMP8 mice fed a Western type diet with 0.15% cholesterol and 20% fat, in 
            which 10% of fat was from olive oil containing either low or high amount of 
                   phenolics (n=10). 
As far as the antioxidant vitamins concerned ascorbic acid content significantly 
increased in SAMP8 LP mice. We measured the mRNA level of genes related to 
ascorbic acid transport or synthesis as an eventual mechanism of the increase. The 
mRNA expression of dominant ascorbic acid transporter in liver (SVCT1) increased 
in SAMP8 LP mice. However the expression of SVCT2 remained unchanged in 
aged mice. This result is in accordance with the study of Michels et al (2003) who 
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found no age related change in rat hepatocytes. It has been reported that primary 
role of SVCT1 is maintenance of the whole-body homeostasis, through dietary 
absorption and renal reabsorption, while SVCT2 is crucial for ascorbic acid uptake in 
metabolically active and specialized tissues, such as eye, brain, skeletal muscle and 
heart (Savini et al., 2008). Beside Kuo et al. (2004) showed that SVCTs appear to 
function independently of each other, as SVCT1 expression and the ascorbate 
concentration in SVCT1-predominant organs such as liver, was not affected by 
SVCT2 deficiency. Furthermore no difference was found in Gulo levels in our study 
suggesting that this increase may not be attributed to de novo ascorbic acid 
synthesis. Also Lykkesfeldt et al. (1998) reported no age associated alteration in rat 
hepatic ascorbic acid synthesis.  
In addition increased level of α-tocopherol was also observed in our aged SAMP8 
mice. This result is in agreement with other studies (Battisti et al., 1994; van der Loo 
et al., 2002; Petusottir et al., 2007). It is suggested that both ascorbic acid and α-
tocopherol levels of SAMP8 mice may increase to counteract the negative effects of 
age related oxidative stress with their antioxidant activities. The increase in α-
tocopherol levels in HP group could not be explained with increased vitamin C level. 
It is supposed that this increase could be due to difference in vitamin E metabolites.  
The membrane bound tocoperoxyl radical may be reduced back to tocopherol by 
ascorbate (Vitamin C). In turn, the ascorbyl radical may be regenerated to ascorbate 
by thiol or polyphenol antioxidants within the so-called antioxidant network (Packer 
et al., 2001). Besides the increase in tocopherol levels may be due to the genes that 
take part in vitamin E metabolism. Therefore we measured the mRNA expression 
levels of genes in vitamin E metabolism. As shown in Figure 4.4 A-H no significant 
change was found for all the genes analysed except the expression of MDR-1 in 
SAMR1 LP and SAMP8 LP groups, which means the increase in vitamin E is may 
be due to the regeneration effect of vitamin C.  
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Figure 4.4 A-H: Relative mRNA expression of genes in vitamin E matabolism (normalized 
                         for GAPDH) of CYP3A (A), TTP (B), LPL (C), LRP1 (D), SRB1 (E), MDR-1 
       (F), LDLR (G), ABCA1(H) in liver of SAMP8 and SAMR1 mice. 
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Present data suggest that SAMP8 mice increase hepatic ascorbic acid uptake via 
SVCT1 as an adaptive response mechanisms. Increased tissue levels of ascorbic 
may in turn affect Nrf2 dependent gene expression thereby impairing stress 
response via enzymatic antioxidant defence mechanisms. Ristow et al. (2010) have 
recently demonstrated that ascorbic acid may interfere with physical exercise related 
induction of the Nrf2 target genes superoxide dismutase and glutathione peroxidase 
in humans. 
Apart from their antioxidant properties, prooxidant activities of ascorbic acid and α-
tocopherol have been described. Ascorbic acid promotes the Fenton reaction in vitro 
and may accelerate non enzymatic lipid peroxidation in various tissues (Halliwell, 
1996). It is also reported that ascorbic acid increases inflammation in ascorbic acid 
deficient mice (Ki et al., 2010), down regulate key genes connected with free radical 
scavenging and repair (Selman et al., 2006) and dose dependently causes 
exacerbating stress contributing to liver injury (Abdul-Rezzak et al., 2010). α-
tocopherol gives rise to the formation of tocopheroxyl radicals in increased oxidative 
stress conditions (Rietjens et al., 2002), it can catalyze hydroperoxide-induced 
hepatocyte lipid peroxidation and cytotoxicity (Tafazoli et al., 2005). Alternatively 
high ascorbic acid and α-tocopherol content in SAMP8 mice may also facilitate 
inflammation and oxidative stress acting as a prooxidant in our study. Further 
studies are required to measure ascorbic acid and α-tocopherol levels in other 
tissues of SAMP8 mice to see whether our findings in liver are in consistent with the 
other tissues regarding oxidative damage. Also the amount of tocopheroxyl radicals 
can be measured in liver to support our statement.  
4.3.6 Effect of age and HP diet on antioxidant phase II enzymes 
Increased attention has been given to induction of phase II enzymes as an important 
mechanism for chemoprevention against carcinogenesis, but the studies in terms of 
correlation between antioxidant enzymes and aging are scarce.  
In the present study, we examined expression levels of γ-GCS, GST-α, NQO-1, HO-
1, PON-1 (in liver) and PON-2 (in heart) genes as Phase II enzymes in heart and 
liver to evaluate the antioxidant capacity. These genes are modulated by ARE 
(antioxidant response element) via binding of Nrf2 transcription factor. Nrf2 is an 
important molecular switch, which orchestrates the gene expression of antioxidant 
and phase II enzymes (Lewis et al., 2010; Sykiotis et al., 2011). Little is known about 
the role of olive oil phenolics on Nrf2 dependent gene expression in vivo. 
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In our study no significant difference was found between SAMR1 LP and SAMP8 LP 
mice in terms of γ-GCS, GST-α, PON-2 and Nrf2 expression levels. On the contrary 
NQO-1 mRNA level was significantly lower (p<0.001) and HO-1 level was 
significantly higher (p<0.05) in SAMP8 LP group. Treatment with phenolic rich olive 
oil improved the levels of γ-GCS and GST-α (p<0.01), NOQ-1, PON-2 and Nrf2 
(p<0.05) significantly in heart (Figure 4.5). No effect was observed in HO-1 level.  
 
Figure 4.5 A-F: Relative mRNA expression (normalized for GAPDH) of Nrf2 (A), GST, (B), γ-GCS, (C) 
                          NQO-1, (D), HO-1 (E), and PON-2 (F) in hearts of SAMP8 mice fed for 4.5 months a 
                          Western type diet with 0.15% cholesterol and 20% fat, in which 10% of fat was from 
                          olive oil containing either low or high amount of phenolics. Values are expressed as  
                          mean ± SEM (n=10). 
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In liver no difference was detected between mice groups regarding Nrf2 modulated 
genes. Only HO-1 mRNA expression was significantly lower (p<0.05) in SAMP8 LP 
group as compared to SAMR1 LP group (Figure 4.7). This decrease was also 
shown in protein level by Western blot (Figure 4.6). We detected a tendency for γ-
GCS and GST-α genes in mRNA level. Therefore we detected the protein level of 
both genes but similarly as observed in mRNA level, no difference was found for the 
protein levels of γ-GCS and GST-α (Figure 4.8).   
 
Figure 4.6: Protein levels of HO-1. Protein levels were determined via western blotting. 
                   Shown is a representative western blot. Values are expressed as the mean 
                   ± SEM (n=10) **p<0.01 SAMR1 vs SAMP8. 
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Figure 4.7 A-F: Relative mRNA expression (normalized for GAPDH) of Nrf2 (A), GST, (B), γ-GCS, 
                          (C), NQO- 1, (D), HO-1 (E), and PON-2 (F) in livers of SAMP8 mice fed for 4.5 months 
                          Western type diet with 0.15% cholesterol and 20% fat, in which 10% of fat was  from 
                          olive oil containing either low or high amount of phenolics. Mice were killed at 7  
                          months of age. Values are expressed as mean ± SEM (n=10). 
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Figure 4.8 A-B: Protein levels of GST-α (A) and γ-GCS (B). Protein levels were determined 
                           via western blotting. Shown is a representative western blot. Values are 
                           expressed as the mean ± SEM (n=10). 
Protective effect of Nrf2 mediated antioxidant enzyme activities on cardiovascular 
diseases and vascular health has been documented (Zhu et al., 2005; Mann et al., 
2007; Mann et al., 2009; Hur et al., 2010). It is suggested that olive oil phenolics 
may exert their modulatory effects on aging, cardiovascular health through Nrf2/ARE 
pathway. It has been recently shown that hydroxytyrosol induces antioxidant/ 
detoxificant enzymes and Nrf2 translocation in hepatocytes (Martin et al., 2010). 
Furthermore hydroxytyrosol induced cytoprotection against oxidative injury in 
vascular endothelial cells via Nrf2 dependent signal transduction pathway (Zrelli et 
al., 2011).  
In studies regarding Nrf2-related genes that were conducted with aged rodents, no 
modulation of Nrf2 was observed neither with mulberry nor bilberry extract in 
SAMP8 mice (Shih et al, 2009). Suh et al. (2004) showed reduced Nrf2/ARE binding 
and Nrf2 mediated gene expression and NQO-1 levels in aging rat liver.   
4.3.7 Effect of age and HP diet on SIRT1 expression 
SIRT1, is a class III deacetylase, that can modulate numerous longevity-promoting 
cellular functions, endothelial function, lipid metabolism, cell cycling, gene 
expression, cardioprotection and aging (Longo and Kennedy, 2006). Previously 
decreased level of SIRT1 expression was documented in SAMP8 mice as compared 
A) B) 
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to its control SAMR1 mice (Pallas et al., 2008; Gutierrez-Cuesta et al., 2008; Tajes 
et al., 2010). In accordance with these studies, the SIRT1 expression level was 
significantly decreased in SAMP8 LP group (p<0.001, Figure 4.9) but high phenolic 
olive oil treatment significantly increased mRNA expression levels in SAMP8 mice in 
our study (p<0.05). SIRT1 exerts its functions by deacetylating variety of metabolic 
transcription factors. A moderate induction of SIRT retarded ageing of the heart and 
induced resistance to oxidative stress (Alcendor et al., 2007). Thus, the decreased 
concentrations of biomarkers of oxidative stress in heart of mice fed the HP diet 
might be related to the moderate SIRT1 induction observed in these animals.  
 
Figure 4.9 A-B: Relative mRNA expression (normalized for GAPDH) of SIRT1 in liver (A) 
                         and heart (B) of mice fed for 4.5 months a Western type diet with 0.15%   
                         cholesterol and 20% fat, in which 10% of fat was from olive oil containing 
                         either low or and high amount of phenolics. Mice were killed at 7 months of 
                         age. Values are expressed as mean ± SEM (n=10). 
4.3.8 Effect of age and HP diet on inflammation markers 
As aging is accompanied by an increase in circulating acute phase reactants we 
measured the CRP and SAP mRNA expression levels as a marker of inflammatory 
status and an increased risk of cardiovascular diseases. Increased levels of CRP 
and SAP together with decreased level of HO-1 indicate that SAMP8 mice have 
higher inflammatory state. These results may also affect PON1 activity, which 
reduced during acute phase response (Ayub et al., 1999). Dullaart et al. (2009) 
reported a lower PON-1 activity related to higher plasma CRP levels in type 2 
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diabetic patients. As shown in figure 4.10 both mRNA expression levels of  CRP and 
SAP increased in SAMP8 LP mkice but no effect of HP treatment was observed.  
 
  
Figure 4.10: Relative mRNA expression (normalized for GAPDH) of SAP and CRP levels in 
                    livers of SAMP8 and SAMR1 mice fed for 4.5 months a Western type diet with 
                    0.15% cholesterol and 20% fat, in which 10% of fat was from olive oil    
                    containing either low or high amount of phenolics. Mice were killed at 7 months 
                    of age. Values are expressed as mean ± SEM (n=10). 
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5. CONCLUSION 
The aim of the present study was to investigate the effect of a diet rich in phenolic 
compounds on the ageing related changes in human model of  ageing, SAMP8 
mice. Most of the studies have focused on the brain ageing of SAMP8 mice and 
effective results are obtained but studies regarding the heart and liver ageing of this 
mice are scarce and needs to be studied. The liver and heart are the major organs 
responsible for a number of physiological processes that are crucial to sustaining 
life. Another aim was to develop and validate a method for the quantification of olive 
oil phenolics with sensitive electrochemical detector. 
As a result the effect of ageing was remarkable in liver of SAMP8 mice as compared 
to SAMR1 mice. This study demonstrates that age dependent oxidative stress and 
inflammation are elevated in SAMP8 mice from a quite early age as compared to its 
control SAMR1 mice which may lead to a rise in free radical formation and thus age 
related diseases. The increase in the protein and lipid oxidation may contribute to 
age related changes as reflected in PON1 activity and expression of inflammation 
related genes (CRP, SAP, HO-1). The amount of vitamin E and vitamin C was also 
higher in SAMP8 LP mice. On the other hand redox status, Nrf2 and Nrf2-dependent 
gene expressions remained to be unchanged in liver. The effect of HP diet was not 
observed except in TBARS and protein carbonyl levels.   
In heart the effect of HP diet was obvious in SAMP8 HP. Feeding a HP diet reduced 
biomarkers of oxidative stress, induced Nrf2 and Nrf2- dependent gene expression 
and increased SIRT1 gene expression in the heart of SAMP8 mice compared to 
animals fed a LP diet. In the literature the effect of Nrf2 dependent antioxidant 
enzyme activities on cardiovascular diseases and vascular health is well known. 
Overall, our results suggest that a diet rich in olive oil phenolics reduces oxidative 
stress in the heart of SAMP8 mice most likely by induction of Nrf2-dependent gene 
expression. Mice fed the HP diet had lower concentrations of TBARS and protein 
carbonyls in the heart than mice on the LP diet. However, proteasomal activity was 
not changed. Thus differences in heart protein carbonyl levels were independent of 
proteasomal activity. Regarding Nrf2 and Nrf2-dependent gene expression and 
redox status no effect was detected in SAMP8 LP mice as compared to SAMR1 LP 
mice.  
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The HP and LP olive oils used in this study had similar profile but they notably 
differed in their content of the major olive oil phenolics hydroxytyrosol, tyrosol, 
oleuropein and pinoresionol which were reflected in the corresponding FRAP and 
TEAC values of the two oils. Importantly, the HP olive oil contained 12-fold higher 
concentrations of total phenolics than the LP olive oil. As far as the main olive oil 
phenolic compound, hydroxytyrosol, is considered, HP oil contains approximately 40 
fold higher hydroxytyrosol than the LP oil. It is suggested that the observed 
beneficial effects of HP diet may be due to high hydroxytyrosol content, which 
seems to be of importance for the potential health benefits of olive oils. 
In conclusion differences in tissue responces to the oxidative stress, different 
profiles of investigated biomarkers were obtained in heart and liver tissue of the 
mice. Some tissues respond to the environmental changes quickly but some tissues 
needs more stressed conditions. We fed the mice with a diet containing 20% fat and 
0.15% cholesterol in order to trigger the oxidative stress. The 9-10 weeks old female 
mice fed either HP or LP diet for 4.5 months and were killed at 7 months old. In the 
literature different results have been obtained depending on the age of SAMP8 
mice. Besides the results differ depending on the experimental design, type of the 
bioactive compound and the amount of the compounds. According to the results of 
our study, it is suggested that the mice were not old enough to see clear effects of 
phenolic rich diet therefore they should be fed longer period of time or older mice 
should be used.    
Another factor for that may be the daily consumption of phenolic compounds. The 
amount of total phenolic compound in HP oil is 532 mg/kg and the diet contains 10% 
olive oil. Thus the amount of phenolics in the diet is 53.2 mg/kg. If the daily feed 
intake of the mice is taken into account, ~2 grams, which means daily amount of 
phenolic consumption is 0.1 mg per mouse. It is a quite low amount to show the 
clear beneficial effects of olive oil phenolics. The differences in tissues of mice fed 
either LP or HP diet may be attributed to low amount of phenolic compound 
consumption.   
In further studies it is suggested to use different ageing models to study the effect of 
olive oil phenolics on ageing and life span. Besides different tissues of SAMP8 mice 
should be considered in order to understand the pathological processes in ageing of 
other tissues.  
In terms of our validated method it is possible to analyze selected phenolic 
compounds (tyrosol, hydroxytyrosol, oleuropein, pinoresinol, caffeic acid, vanillic 
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acid, p-coumaric acid, ferulic acid) in 17 minutes. This method was validated in 
terms of selectivity, lower limit of quantification and detection, accuracy, precision, 
recovery, short term stability, freeze thaw stability and post preparative stability. The 
phenolics were quantified in ng level. The recoveries of these phenolic compounds 
ranged between 72-96%. This method may also be used in biological samples 
(urine, blood, tissues) to analyse the phenolics and as well as their metabolites.   
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Figure A.1: Representative chromatogram of the standards 1) hydroxytyrosol 2) 
                    tyrosol 3) caffeic acid 4) vanillic acid 5) ferulic acid 6) p-coumaric acid 
                    7)oleuropein 8) pinoresinol IS: internal standard. 
 
 
Figure A.2: Representative chromatogram of the olive oil extract1) hydroxytyrosol 
                    2) tyrosol 3) caffeic acid 4) vanillic acid 5) ferulic acid 6) p-coumaric   
                    acid 7) oleuropein 8) pinoresinol IS: internal standard. 
 
 
APPENDIX A:  Chromatograms 
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Figure A.3: Representative chromatogram of the blank olive oil extract. 
 
 
Figure A.4: Representative chromatogram of α- and γ-tocopherol. 
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APPENDIX B: Calibration Curves 
 
 
Figure B.1: Calibration curve for FRAP assay. 
 
Figure B.2: Calibration curve for TEAC assay. 
 
Figure B.3: Calibration curve for the determination of total phenolics. 
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Figure B.4: Calibration curve for tyrosol. 
 
Figure B.5: Calibration curve for hydroxytyrosol. 
 
Figure B.6: Calibration curve for vanillic acid.  
 
Figure B.7: Calibration curve for caffeic acid.  
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Figure B.8: Calibration curve for p-coumaric acid. 
 
Figure B.9: Calibration curve for ferulic acid.  
 
Figure B.10: Calibration curve for oleuropein. 
 
Figure B.11: Calibration curve for pinoresinol.
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APPENDIX C:  
Table C.1: The list of olive oil samples that are analyzed in the study.  
Sample Country Region Olive variety Harvest year Extraction Type 
1 Spain  n.a. Lechin  2007  Cold pressed Extra virgin  
2 Spain  n.a. Picual  2007  Cold pressed Extra virgin  
3 Spain  n.a. Hojiblanca 2007  Cold pressed Extra virgin  
4 Spain  n.a. Arbequina  2007  Cold pressed Extra virgin  
5 Spain  Andalusia Picual  2008 Cold pressed Extra virgin  
6 Spain  n.a. n.a. n.a. Cold pressed Extra virgin  
7 Spain  n.a. n.a. n.a. Cold pressed Extra virgin  
8 Spain  n.a. n.a. n.a. Cold pressed Extra virgin  
9 Spain  n.a. n.a. n.a. Cold pressed Extra virgin  
10 Spain  n.a. n.a. n.a. Cold pressed Extra virgin  
11 Spain  n.a. n.a. n.a. Cold pressed Extra virgin  
12 Spain  n.a. n.a. n.a. Cold pressed Extra virgin  
13 Turkey  Ezine  n.a. 2008 Cold pressed Extra virgin  
14 Turkey Zeytindağ  n.a. 2008  Cold pressed Extra virgin  
15 Turkey Aydin  Memecik  2007  Cold pressed Extra virgin  
16 Turkey Hatay  Saurani  n.a. Cold pressed Extra virgin  
17 Turkey Hatay  Hasebi  n.a. Cold pressed Extra virgin  
18 Turkey Hatay  Halhali  n.a. Cold pressed Extra virgin  
19 Turkey Hatay  Multivariety  n.a. Cold pressed Extra virgin  
20 Turkey n.a. n.a. n.a. Cold pressed Extra virgin  
21 Turkey n.a. n.a. n.a. Cold pressed Extra virgin  
22 Turkey n.a. n.a. n.a. Cold pressed Extra virgin  
23 Turkey n.a. n.a. n.a. Cold pressed Extra virgin  
24 Turkey Ayvalik Ayvalık  2007 Cold pressed Extra virgin  
25 Italy  Sicily Tonda iblea 2008 Cold pressed Extra virgin  
26 Italy  n.a. n.a. n.a. Cold pressed Extra virgin  
27 Italy  n.a. n.a. n.a. Cold pressed Extra virgin  
28 Italy  n.a. n.a. 2007 Cold pressed Extra virgin  
29 Italy  Sicily  Cerasuola,Nocellara,Biancolilla 2007 Cold pressed Extra virgin  
110 
 Table C.1 (continued): The list of olive oil samples that are analyzed in the study. 
 
 
 
 
 
 
Sample Country Region Olive variety Harvest year Extraction Type 
30 Italy  n.a. n.a. n.a. Cold pressed Extra virgin  
31 Italy  n.a. n.a. n.a. Cold pressed Extra virgin  
32 Italy  n.a. n.a. n.a. Cold pressed Extra virgin  
33 Italy  n.a. n.a. n.a. Cold pressed Extra virgin  
34 Italy  n.a. n.a. n.a. Cold pressed Extra virgin  
35 Greece  Lakonia  Koroneiki,Athinoleia 2007  Cold pressed Extra virgin  
36 Greece  Kalamata  Koroneiki 2007  Cold pressed Extra virgin  
37 Greece  Crete  Koroneiki 2007  Cold pressed Extra virgin  
38 Greece  Sitia, Crete  Koroneiki 2007  Cold pressed Extra virgin  
39 Greece  Crete Koroneiki 2007 Cold pressed Extra virgin  
40 Greece  Crete Koroneiki 2007  Cold pressed Extra virgin  
41 Greece  Mani Koroneiki 2007  Cold pressed Extra virgin  
42 Greece  Kolymvari, Crete Koroneiki n.a. Cold pressed Extra virgin  
43 France  Ollioules Brun  2008  Cold pressed Extra virgin  
44 France  Ollioules Cayon  2008  Cold pressed Extra virgin  
45 France  Ollioules Multivariety  2008  Cold pressed Extra virgin  
46 France  n.a. n.a. 2008 Cold pressed Extra virgin  
47 Portugal  Alentejo 80% Arbequina, 20%Cobrançosa 2007  Cold pressed Extra virgin  
48 Portugal  Alentejo 80% Arbequina, 20%Cobrançosa 2007 Cold pressed Extra virgin  
49 Portugal  n.a. n.a. 2007 Cold pressed Extra virgin  
50 Portugal  n.a. n.a. 2007 Cold pressed Extra virgin  
51 Australia  Kiewa River Lechino  2008  Cold pressed Extra virgin  
52 Australia  Frankland River Lechino  2007 Cold pressed Extra virgin  
53 Australia Frankland River Frantoio  2007 Cold pressed Extra virgin  
54 USA California  Manzanillo, Mission 2007 Cold pressed Extra virgin  
55 USA California  Lechino  2007  Cold pressed Extra virgin  
56 USA California  Frantoio  2007  Cold pressed Extra virgin  
57 South Africa  Morgenster  Frantoio, leccino, coratina 2007  Cold pressed Extra virgin 
Abbreviations: n.a; not available 
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APPENDIX D: Statistical values 
Table D.1: p values of t-test for the analysed parameters in serum of mice 
ANALYSED 
PARAMETER  
SAMR1 LP vs SAMP8 LP SAMP8 LP vs SAMP8 HP 
Triglyceride  0.29 0.07 
Total cholesterol  0.002 0.23 
HDL  0.13 0.84 
PON1 activity  0.0001 0.024 
Table D.2: p values of t-test for the analysed parameters in heart of mice 
ANALYSED 
PARAMETER 
SAMR1 LP vs SAMP8 LP SAMP8 LP vs SAMP8 HP 
TBARS 0.013 0.0001 
Protein carbonyl 0.031 0.004 
Proteasomal activity  
β-1 subunit 0.173 0.15 
β-2 subunit 0.06 0.06 
β-5 subunit 0.357 0.35 
GSH 0.13 0.088 
Cysteine 0.03 0.03 
Methionine 0.17 0.10 
Uric acid 0.021 0.027 
Ascorbic acid 0.12 0.10 
Nrf-2 0.76 0.036 
GST 0.005 0.10 
γ-GCS 0.66 0.06 
NQO-1 0.001 0.028 
HO-1 0.003 0.86 
PON-2 1.00 0.004 
SIRT-1 0.029 0.006 
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Table D.3: p values of t-test for the analysed parameters in liver of mice 
ANALYSED 
PARAMETER  
SAMR1 LP vs SAMP8 LP SAMP8 LP vs SAMP8 HP 
TBARS  0.002 0.66 
Protein carbonyl  0.016 0.008 
Proteasomal activity   
  β-1 subunit  0.63 0.98 
  β-2 subunit  0.87 0.26 
  β-5 subunit 0.02 0.16 
GSH 0.63 0.33 
GSSG 0.10 0.56 
Cysteine  0.005 0.46 
Methionine  0.86 0.51 
Uric acid 0.20 0.16 
Ascorbic acid 0.003 0.76 
SVCT1 0.029 0.71 
SVCT2 0.38 0.29 
GLUOX 0.77 0.0001 
Vitamin E 0.0001 0.0001 
CYPA3 0.28 0.81 
TTP 0.32 0.69 
LPL 0.08 0.53 
LRP1 0.77 0.92 
SRB1 0.76 0.09 
MDR-1 0.0001 0.11 
LDLR 0.36 0.72 
ABCA1 0.22 0.17 
Nrf-2 0.09 0.71 
GST 0.16 0.12 
GST (protein level) 0.84 0.15 
γ-GCS 0.22 0.33 
γ-GCS (protein level) 0.49 0.40 
NQO-1 0.069 0.53 
HO-1 0.24 0.65 
HO-1 (protein level) 0.01 0.87 
PON-1 0.47 1.00 
SIRT-1 0.35 0.33 
SAP 0.016 0.57 
CRP 0.004 0.30 
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